// Reference=MNI
// Gelnar P A, 1999: Thermal Painful vs. Rest
// Subjects=8
16.68	-5.26	76.48
-4.65	-15.97	77.62
-38.92	-19.14	67.13
-38.91	-23.37	67.48
-45.47	-22.84	47.44
-60.66	-7.72	24.04
-19.89	-25.48	38.45
-43.65	-8.48	12.76
-32.44	-33.74	70.51

// Coghill R C, 1994: Pain vs. Neutral
// Subjects=9
24	-31	56
36	-6	18
38	6	9
1	1	42
1	-4	54
5	-6	66
11	-19	-3
-25	1	-8
-23	-7	6
75	15	-3
68	17	8
-71	22	-3
-70	15	-13
34	53	30

// Coghill R C, 1994: Pain vs. Vibration
// Subjects=9
42	15	9
-71	17	0
68	13	-11

// Deuchert M, 2002: 2nd Finger - Rest, Subject 1
// Subjects=1
-41.14	-28.81	52.35
-44.29	-28.23	60.14
-44.25	-41.01	60.1
-50	-22.17	15.09
46.15	-21.86	10.62

// Deuchert M, 2002: 2nd Finger - Rest, Subject 2
// Subjects=1
-41.11	-31.73	55.94
-41.04	-34.3	63.96
-51.79	-35.05	55.23
-46.79	-22.16	15.06
60.08	-18.09	16.83

// Deuchert M, 2002: 2nd Finger - Rest, Subject 3
// Subjects=1
-50.75	-25.44	55.52
-57.17	-25.57	54.49
-47.52	-41.71	51.28
-47.83	-25.08	18.66
58.01	-24.01	22.93

// Deuchert M, 2002: 2nd Finger - Rest, Subject 4
// Subjects=1
-37.92	-22.02	57.32
-28.19	-20.85	71.61
-47.84	-21.9	18.39
48.29	-18.5	12.54

// Deuchert M, 2002: 2nd Finger - Rest, Subject 5
// Subjects=1
-44.37	-22.49	51.86
-51	-21.5	23.97
56.93	-20.76	23.78

// Deuchert M, 2002: 2nd Finger - Rest, Subject 6
// Subjects=1
-44.58	-27.97	22.21
45.12	-24.78	14.22

// Deuchert M, 2002: 2nd Finger - Rest, Group Mean
// Subjects=6
-47.83	-24.02	18.57
52.61	-21.3	17.19

// Deuchert M, 2002: 5th Finger - Rest, Subject 1
// Subjects=1
-37.93	-32.05	51.47
-44.31	-21.89	59.61
-44.25	-41.01	60.1
-52.14	-22.19	15.12

// Deuchert M, 2002: 5th Finger - Rest, Subject 2
// Subjects=1
-41.09	-34.9	56.21
-41.03	-34.22	65.07
-50.71	-34.96	56.32
-47.85	-22.08	16.18
60.08	-18.09	16.83

// Deuchert M, 2002: 5th Finger - Rest, Subject 3
// Subjects=1
-44.28	-34.75	58.46
-47.82	-24.99	19.77
58	-22.96	22.84

// Deuchert M, 2002: 5th Finger - Rest, Subject 4
// Subjects=1
-33.64	-25.25	56.43
-28.19	-20.85	71.61
-49.97	-21.83	19.53
48.28	-18.58	11.43

// Deuchert M, 2002: 5th Finger - Rest, Subject 5
// Subjects=1
-49.93	-21.4	25.07
54.8	-20.78	23.81

// Deuchert M, 2002: 5th Finger - Rest, Subject 6
// Subjects=1
-50.98	-31.18	22.55
44.05	-24.78	14.23

// Deuchert M, 2002: 5th Finger - Rest, Group Mean
// Subjects=6
-49.96	-23.95	19.7
52.62	-21.22	18.3

// Ploner M, 2000: Tactile Stimulation vs. Rest
// Subjects=6
40.07	-19.52	55.1
29.46	-25.42	62.41
51.48	-8.79	13.92
-51.06	-12.24	19.85

// Ploner M, 2000: Nociceptive Stimulation vs. Rest
// Subjects=6
29.47	-25.33	63.52
55.74	-5.59	13.6
-53.2	-13.39	18.86

// Derbyshire S W G, 1998: Noxious Heat vs. Innocuous Heat
// Subjects=6
-9.73	34.94	-6.89
5.61	14.85	34.77

// Remy F, 2003: Main effect of pain task
// Subjects=12
-30	4	42
-40	16	40
-60	12	26
-14	-74	26
-6	-72	22
-24	-78	30
-6	8	30

// Remy F, 2003: Positive modulation effect of pain on semantic
// Subjects=12
-50	-6	20
-52	-30	42
-54	-34	30
-14	-76	46
-14	-84	40
4	-68	30
2	60	22
8	62	2
12	4	34
4	-28	-6

// Bantick S J, 2002: Positive Interaction
// Subjects=8
18	44	2
-10	32	-2

// Nunneley S A, 2002: Heating - Rest
// Subjects=9
3.52	-39.57	19.28
-30.57	-54.07	27.58
-26.78	-39.29	-29.46
-37.52	-50.96	-41.74
-26.77	-59.01	-36.73
-5.3	-16.13	-7.11
14.27	-27.91	31.56
-3.26	-19.26	-20.26
-1.09	-10.1	-12.13

// Becerra L R, 1999: Regions Positively Activated By 46° C, Group 1
// Subjects=6
14.17	31.54	43.31
4.54	-33.48	15.42
1.07	45.01	12.22
34.3	2.39	8.72
40.31	-5.11	-47.6
7.28	8.92	-28.32
43.45	44.84	-35.09
23.09	61.63	-36.27
7.47	-49.49	-26.77
62.97	-2.66	-17.95
44.19	-35.39	28.5
4.35	-72.77	-24.78
16.99	-64.72	-45.67
3.67	56.29	-62.36
20.57	-60.85	4.14
-26.05	-19.74	-65.68

// Becerra L R, 1999: Regions Positively Activated By 41° C, Group 1
// Subjects=6
7.76	31.5	43.39
7.37	47.19	-1.42
10.95	-46.64	9.76
34.28	2.14	5.4
37.31	-12.84	-23.49
10.53	17.12	-19.01
70.17	4.33	-52.08
50.23	-53.46	-26.93
26.24	63.25	-43.13
17.5	5.38	48.81
17.14	-69.78	-28.52
33.98	46.32	-15.03
-29.26	9.82	-54.74

// Becerra L R, 1999: Regions Positively Activated By 46° C, Group 2
// Subjects=6
34.42	34.31	36.15
10.64	44.55	5.46
14.15	-30.25	15.03
43.92	2.45	8.6
30.76	2.21	-34.72
7.28	8.92	-28.32
63.73	24.9	-47.03
34.24	-63.08	-25.94
26.31	44.22	-41.53
62.99	-9.01	-17.42
-2.14	-57.21	-29.36
33.98	46.32	-15.03
-15.32	-30.25	-64.92

// Bingel U, 2002: Main Effect of Pain
// Subjects=14
21	-21	-9
-21	-21	-12
18	-6	-18
-15	-6	-15
9	-12	3
-9	-15	3
39	-54	30
-39	-57	-27
21	9	-6
-27	9	-3
12	-12	-6
-6	-21	-6

// Bornhovd K, 2002: Stimulus Perception
// Subjects=9
54	30	21
-48	27	21
33	6	27
-48	9	21
45	-51	54
-36	-60	57

// Bornhovd K, 2002: Stimulus Intensity
// Subjects=9
51	-27	45
-42	-21	54

// Bornhovd K, 2002: Pain
// Subjects=9
-6	36	-12
42	-12	6
-45	-18	12
51	15	-9
-45	12	-9
36	9	0
-42	9	-6
24	0	-24
-27	0	-27
-6	54	12

// Casey K L, 1996: Warm (36 C vs. 43 C)
// Subjects=27
-.17	54.2	-6.38
-17.07	6.69	0.03
-7.36	-24.09	0.27
2.2	-54.3	-19.61

// Casey K L, 1996: Heat  Pain (40 C vs. 50 C)
// Subjects=27
-59.74	0.69	8.83
-26.21	-12.52	55.27
-9.34	7.19	33.35
-30.95	10.04	3.25
-38.27	-17.96	13.49
-7.38	-14.4	1.69
59.94	3.52	7.22
7.64	-13.71	9.26
2.12	-37.55	-23.25
9.76	-55.59	-9.55

// Casey K L, 1996: Cold Pain (20 C vs. 6 C)
// Subjects=27
-53.34	0.56	6.54
-24.07	-17.97	53.48
-4.92	-5.59	46.64
-26.69	6.63	0.14
-9.47	-18.39	5.39
28.84	49.4	11.53
2.43	7.43	35.43
42.86	5.79	10.57
2.28	-18.32	5.25
2.21	-52.01	-17.57

// Coghill R C, 2001: Pain Intensity-Dependent, Left Stimulation
// Subjects=9
-16.1	-64.5	-48.2
-38.1	-56.5	-48.2
-10.1	-52.5	-40.2
-46.1	-54.5	-34.2
-26.1	-52.5	-30.2
-8.1	-62.5	-22.2
-.1	-68.5	-16.2
-.1	-64.5	-16.2
37.9	-48.5	-48.2
33.9	-54.5	-36.2
39.9	-52.5	-36.2
27.9	-68.5	-26.2
21.9	-66.5	-24.2
17.9	-64.5	-22.2
17.9	-60.5	-14.2
3.9	-60.5	-14.2
1.9	-56.5	-12.2
-30.1	-10.5	1.8
27.9	1.5	5.8
25.9	3.5	13.8
-16.1	-20.5	9.8
-12.1	-14.5	9.8
-18.1	-16.5	11.8
-16.1	-20.5	13.8
15.9	-8.5	11.8
21.9	-18.5	13.8
-46.1	-.5	7.8
49.9	9.7	5.8
53.9	5.5	9.8
31.9	1.5	3.8
33.9	-20.5	15.8
37.9	-20.5	17.8
43.9	-18.5	15.8
49.9	-16.5	15.8
55.9	-30.5	23.8
43.9	-34.5	27.8
49.9	-34.5	27.8
31.9	-28.5	61.8
21.9	-40.5	63.8
27.9	-30.5	63.8
21.9	-42.5	67.8
-8.1	23.5	29.8
-6.1	15.5	31.8
-4.1	7.5	41.8
-.1	5.5	41.8
1.9	9.5	39.8
1.9	-2.5	47.8
-8.1	-8.5	71.8
-12.1	-6.5	71.8
5.9	-6.5	59.8
19.9	-10.5	63.8
5.9	-2.5	63.8
-.1	-26.5	-14.2
-10.1	-20.5	-8.2

// Coghill R C, 2001: Pain Intensity-Dependent, Right Stimulation
// Subjects=9
-34.1	-52.5	-36.2
-6.1	-50.5	-34.2
-30.1	-58.5	-32.2
-20.1	-64.5	-28.2
-18.1	-62.5	-24.2
37.9	-48.5	-50.2
33.9	-52.5	-30.2
21.9	-68.5	-24.2
21.9	-62.5	-24.2
23.9	-56.5	-24.2
13.9	-40.5	-24.2
3.9	-50.5	-16.2
3.9	-44.5	-16.2
3.9	-50.5	-12.2
1.9	-54.5	-10.2
-28.1	-4.5	11.8
-28.1	-10.5	13.8
29.9	11.5	-2.2
-12.1	-16.5	-.2
-8.1	-14.5	-.2
-4.1	-6.5	-.2
9.9	-10.5	7.8
-50.1	5.5	5.8
55.9	11.5	9.8
-30.1	-14.5	13.8
-40.1	-28.5	21.8
-40.1	-24.5	21.8
-36.1	-34.5	59.8
-32.1	-34.5	61.8
-26.1	-36.5	67.8
-18.1	-14.5	65.8
-22.1	-20.5	67.8
3.9	7.5	39.8
5.9	11.5	39.8
5.9	7.5	43.8
3.9	3.5	47.8
5.9	1.5	59.8
7.9	1.5	63.8
1.9	-.5	53.8
-18.1	-48.5	55.8
-22.1	-44.5	73.8
15.9	-4.5	9.8

// Coghill R C, 2001: Pain Intensity-Independent, Left Stimulation
// Subjects=9
25.9	-38.5	61.8
49.9	-20.5	15.8
53.9	-24.5	19.8
49.9	-32.5	21.8
57.9	-28.5	23.8
19.9	-18.5	13.8
15.9	-16.5	17.8
31.9	-42.5	39.8
49.9	-38.5	43.8
39.9	37.5	21.8
37.9	41.5	21.8
33.9	49.5	21.8
27.9	47.5	25.8
39.9	33.5	31.8
41.9	29.5	33.8
35.9	-.5	55.8
33.9	-2.5	59.8
39.9	7.5	55.8
-28.1	-60.5	-46.2
-28.1	-48.5	-44.2
-38.1	-58.5	-34.2
-36.1	-54.5	-30.2
-16.1	-68.5	-26.2
-20.1	-60.5	-26.2
-26.1	-46.5	-26.2
49.9	1.5	3.8
-52.1	-24.5	27.8
-52.1	-30.5	29.8
47.9	-36.5	25.8
7.9	-8.5	53.8
3.9	-.5	53.8
1.9	3.5	55.8
23.9	-16.5	69.8
21.9	-12.5	69.8
29.9	1.5	11.8

// Coghill R C, 2001: Pain Intensity-Independent, Right Stimulation
// Subjects=9
-32.1	-38.5	57.8
-32.1	-38.5	61.8
-52.1	-20.5	19.8
-42.1	-24.5	21.8
-40.1	-52.5	49.8
13.9	-10.5	11.8
49.9	-44.5	47.8
43.9	45.5	17.8
39.9	7.5	55.8
-32.1	-64.5	-42.2
-34.1	-48.5	-38.2
-34.1	-58.5	-36.2
-34.1	-52.5	-36.2
23.9	-54.5	-46.2
23.9	-54.5	-42.2
25.9	-54.5	-38.2
33.9	-54.5	-34.2
29.9	-66.5	-26.2
-46.1	1.5	7.8
-50.1	3.5	7.8
-38.1	7.5	9.8
43.9	19.5	1.8
55.9	5.5	7.8
55.9	9.5	7.8
-52.1	-26.5	25.8
-50.1	-32.5	29.8
-48.1	-28.5	29.8
-48.1	-40.5	33.8
-2.1	5.5	51.8
1.9	7.5	49.8
31.9	41.5	-14.2
37.9	45.5	-12.2
43.9	49.5	-10.2
-38.1	-48.5	51.8
-36.1	-44.5	55.8
-34.1	-20.5	11.8
-32.1	3.5	13.8

// Coghill R C, 2001: Quantitatively Lateralized Regions
// Subjects=9
13.9	-14.5	11.8
51.9	-44.5	45.8
43.9	41.5	23.8
43.9	35.5	31.8
39.9	9.5	57.8

// Coghill R C, 2001: Qualitatively Lateralized Regions
// Subjects=9
-32.1	-64.5	-42.2
-30.1	-42.5	-42.2
63.9	-30.5	23.8
5.9	13.5	45.8

// Coghill R C, 1999: Brain Activation Positively Related to Perceived Pain 
// Intensity
// Subjects=16
3.9	-46.5	-16.2
11.9	-62.5	-24.2
-28.1	9.5	-.2
23.9	-2.5	-.2
-20.1	-18.5	-.2
-.1	-18.5	-.2
9.9	-14.5	-.2
-38.1	1.5	-4.2
-44.1	-10.5	-.2
33.9	17.5	-.2
-60.1	7.5	3.8
-62.1	-.5	11.8
49.9	9.5	-.2
55.9	1.5	7.8
-38.1	-12.5	19.8
-50.1	-26.5	19.8
49.9	-12.5	15.8
-.1	11.5	35.8
-.1	-2.5	47.8
-.1	-.5	51.8
-24.1	-38.5	59.8
-18.1	-14.5	59.8

// Coghill R C, 1999: Brain Activation Independent of Perceived Pain Intensity
// Subjects=16
35.9	51.5	-8.2
27.9	39.5	23.8

// Coghill R C, 2003: High Sensitivity
// Subjects=6
-2	8	36
-4	18	24
-4	-34	58
30	64	0
32	62	-8
32	52	-18
-18	-20	14

// Coghill R C, 2003: Low Sensitivity
// Subjects=6
-4	18	24
-18	-20	14

// Coghill R C, 2003: Difference Between High and Low Sensitivity
// Subjects=6
-2	8	36
-4	18	24
-4	-34	58
30	64	0
32	62	-8
32	52	-18

// Giesecke T, 2004: Pain vs. Rest, HC
// Subjects=11
57	-27	46
55	-21	12
53	-44	50
50	-23	16
2	4	46
-69	-17	19
-36	-65	-22

// Ibinson J W, 2004: Tingling vs. Rest
// Subjects=6
-20	-32	-8
-30	-2	-12
-48	-28	14
-68	-24	36

// Ibinson J W, 2004: Pain vs. Rest
// Subjects=6
38	-80	-32
-24	-22	8
-46	-10	-6
52	-24	12
-64	-30	8
-8	-10	46
-38	-30	50

// Ibinson J W, 2004: Pain vs. Tingling (Main Effect)
// Subjects=6
12	-56	-28
-18	-24	0
-68	-28	26
-14	-4	38
-6	-20	50
-34	-28	52

// Nemoto H, 2003: Brain Activation Before Fluvoxamine Administration
// Subjects=12
-4	16	30
4	18	28
-16	-18	4
14	-22	12
-34	-6	12
42	-2	6
-24	-2	8
30	-12	8
44	-22	18
66	-38	32
-20	-78	-32
30	-46	-46
2	-24	-6

// Smith K A, 2002: Noxious Pain vs. Non-Noxious Warm Stimulation
// Subjects=8
34	22	-2
-30	20	-2
58	8	-2
-52	-10	6
2	12	34
-56	-20	16
58	-18	14
40	42	18
-36	42	18
2	-72	2
28	-62	-32
-30	-76	-30
-38	-56	-30

// Strigo I A, 2003: Painful Esophageal Distention
// Subjects=7
52	-27	29
-52	-33	30
52	-18	25
-60	-16	25
30	20	6
34	0	2
-36	2	6
-26	-16	4
42	-10	36
-50	-10	34
2	10	48
-38	-58	52
-14	-68	38
-2	26	36
30	-56	-30
-24	-60	-22
-32	-56	-32
0	-50	-22
26	-12	4
-22	-2	4
-14	-14	6

// Strigo I A, 2003: Painful Thermal Heat
// Subjects=7
32	12	8
32	24	6
-36	2	16
-36	12	10
36	-4	-6
-42	0	2
36	-20	14
-28	-22	6
54	-38	32
-56	-24	16
42	50	-2
38	-50	42
-34	-48	38
54	-36	44
-60	-38	38
-2	-26	28
-10	0	42
-16	-14	6
36	-56	-44
28	-56	-30
-40	-52	-44
-26	-66	-32
4	-58	-30
26	6	4
-30	-6	6

// Svensson P, 1998: High - Low, Tonic Activations
// Subjects=10
-29	-26	62
-40	-19	15
0	41	5
5	22	-5
-46	1	2
-4	-9	14
-21	-14	75
29	10	11
39	-16	18
5	-68	-30

// Svensson P, 1998: High - Low, Phasic Activations
// Subjects=10
-43	-23	62
-51	-11	12
4	8	47
1	-1	37
-38	5	11
-23	-13	62
37	-1	15
32	-18	12
32	-45	-35

// Svensson P, 1998: Low - Warmth, Phasic Activations
// Subjects=10
-7	-6	39
-19	1	21
39	-56	48
21	-61	-33

// Svensson P, 1998: High - Warmth, Phasic Activations
// Subjects=10
-27	-16	65
-51	-4	6
-5	-4	41
-43	5	2
-3	-26	2
-51	-4	6
-19	3	9
-24	-59	-35
23	-57	-27

// Xu X, 1997: Hand vs. Rest
// Subjects=6
39.96	-4.79	-4.79
35.71	4.54	3.32
12.48	12.86	47.72
50.93	9.68	11.52
-27.04	14.54	-1.08
35.72	48.33	12.44
57.66	-38.81	20.68
-48.46	9.33	13.25
-39.9	15.32	8.02
14.14	-19.35	1.57
-54.72	-32.82	22.01
-20.74	-58.96	-29.78
33.37	-82.17	-28.4

// Xu X, 1997: Foot vs. Rest
// Subjects=6
-54.72	-34.95	22.22
10.31	17.11	47.33
44.35	19.87	6.14
37.8	8.38	-1.58
55.5	-38.82	20.72
35.49	18.18	-11.47
22.67	-4.85	-4.49
-50.68	8.9	8.84
-27.12	18.38	-5.94

// Xu X, 1997: Hand vs. Foot
// Subjects=6
29.62	-66.98	19.47
36.49	-33.44	56.37

// Xu X, 1997: Foot vs. Hand
// Subjects=6
-54.75	-39.62	18.2
37.63	22.44	-11.93

// Becerra L R, 2001: (Warm + Noxious) - Baseline, Early Phase
// Subjects=8
4.75	5.98	57.83
17.64	0.23	64.85
14.28	15.04	50.27
-41.58	5.11	9.36
17.7	-15.63	66.18
40.57	27.3	-.13
-65.15	7.63	2.73
23.34	35.68	-14.02
61.15	-19.14	16.91
58.14	-27.05	38.79
-64.75	-40.98	34.68
37.51	-4.19	5.89
-47.99	-8.13	3.86
-44.65	-16.6	17.91
60.96	5.21	1.49
-65.02	-14.06	11.24
-32.21	-20.46	-33.21
4.63	8.04	43.16
-5.17	15.96	22.53
1.36	4.08	33.49
14.31	-24.14	39.05
20.34	-5.06	-3.88
-11.78	17.21	-2.03
10.73	11.51	4.88
10.78	-14.38	0.36
-11.6	-17.17	7.54
1.14	-21.29	-5.64
-15.07	-23.27	-29.82
-32.09	-45.58	-27.76
30.87	-56.01	-44.33
-25.6	-57.89	-22.34

// Becerra L R, 2001: Warm - Baseline, Early Phase
// Subjects=8
4.44	45.6	33.32
50.54	11.23	39.02
58.08	-47.45	22.66
1.22	35.55	27.51

// Becerra L R, 2001: (Warm + Noxious) - Baseline, Late Phase Increases
// Subjects=8
-5.04	37.14	48.64
4.58	27.33	44.89
-44.52	-8.63	38.43
-38.22	36.34	41.28
-52.09	16.71	36.39
43.53	1.68	-42.63
1.19	35.29	24.18
14.01	12.3	14.81
10.85	-33.41	1.96

// Becerra L R, 2001: Warm - Baseline, Late Phase
// Subjects=8
-15.02	6.99	-10.06

// Bingel U, 2003: Right Hand - Baseline
// Subjects=14
27	-30	51
-36	-42	51
51	-24	21
-54	-24	24
39	0	9
-39	6	0
9	-3	39
-3	-6	51
12	-9	0
-12	-18	0

// Bingel U, 2003: Left Hand - Baseline
// Subjects=14
27	-30	51
-33	-51	51
54	-27	18
-57	-27	18
36	6	9
-36	0	12
3	-3	42
-9	-6	42
15	-18	9
-12	-15	3

// Bingel U, 2003: Conjunction Analysis
// Subjects=14
33	-36	71
-33	-36	71
51	-27	24
-51	-27	24
38	-18	15
-38	-18	15
36	-18	9
-36	-18	9
12	-18	9
-12	-18	9

// Derbyshire S W G, 2002: Regions of rCBF Correlated with Pain Ratings 
// (Controls)
// Subjects=16
6	-34	-34
4	-24	-8
-16	-12	8
16	-22	4
-22	12	4
28	2	4
8	28	24
4	12	32
-28	34	28
-52	-44	24
56	-44	24

// Derbyshire S W G, 1997: Pain vs. Warm, Activations
// Subjects=12
-28.88	-25.76	-19.42
-30.94	-.8	0.82
-24.54	1.36	0.56
22.45	1.3	-4.43
-3.18	-3.09	-3.77
11.91	-19.23	6.33
-33.26	47.83	-3.24
-48.01	10.36	9
32.98	52.46	-4.39
50.3	10.95	7.82
5.29	46.63	5.34
-39.04	-55.55	36.73
48.54	-44.45	34.79
-52.02	-24.25	29.79
1.31	32.09	37.83
-30.64	11.09	44.42
39.85	13.28	38.97

// Derbyshire S W G, 2002: Males
// Subjects=11
50	-46	44
-40	-56	40
24	-6	66
-58	-28	22
40	42	20
-42	36	12
-32	52	-4
-2	30	40
-2	20	46
-10	34	40
14	-24	4
-24	-12	0
-32	-14	4
36	-6	-4
40	16	6
-42	4	14

// Derbyshire S W G, 2002: Females
// Subjects=11
46	-64	40
58	-42	42
54	2	38
-30	2	52
56	8	8
46	46	-2
40	46	-12
0	30	30
8	26	42
-2	-10	-12
8	48	0
56	8	8
-28	10	-4

// Derbyshire S W G, 2002: Males + Females
// Subjects=11
48	-54	50
-42	-58	42
56	-42	42
42	10	46
-36	-2	54
52	10	4
-56	4	-12
-60	-26	22
42	44	18
-38	42	16
46	44	6
-32	52	-4
-2	30	36
-2	22	46
14	20	24
-10	32	38
16	-26	8
-24	-12	-2
-34	-12	2
36	-8	-4
40	12	2
-40	20	16

// Jones A K P, 1997: Pain vs. Non-Painful, Normals
// Subjects=6
3.26	-46.72	-18.03
-26.72	-12.37	-11.64
-11.42	6.63	40.12
28.76	46.43	0.63
20.36	43.52	18.81
59.18	-40.5	29.87

// Lorenz J, 2002: HTPn-2°C, Normal - Rest
// Subjects=14
4.44	-23.59	5.67
-7.28	-25.43	10.42
21.24	18.49	-15.9
57.72	14.8	1.83
-38.46	21.79	4.58
52.66	-26.25	22.06
60.29	-42.26	34.47
11.97	34.09	35.31
42.59	50.23	-6.54
48.2	27.83	19.81
-53.31	20.7	19.34

// Lorenz J, 2002: HTPn+2°C, Normal - Rest
// Subjects=14
-9.42	-23.33	10.26
17.16	12.78	6.93
38.45	14.25	-3.47
-40.61	19.49	2.57
55.89	-25.97	25.35
52.93	-60.83	42.8
17.3	36.24	35.07
42.56	52.17	-8.93

// Svensson P, 1997: Cutaneous Laser
// Subjects=11
-26.21	-12.52	55.27
-43.61	-8.13	17.19
-45.89	6.94	5.91
-11.64	-18.66	2.09
-46.03	50.47	4.5
-53.07	-26.28	31.09
52.48	3.73	10.63
4.32	-66.51	-26.42

// Svensson P, 1997: Intramuscular Electrical
// Subjects=11
-26.21	-12.52	55.27
0.28	7.25	33.24
-14.87	-12.33	1.6
-49.81	-33.41	34.99
-19.21	2.28	-1.81
33.2	-66.08	-23.44

// Tolle T R, 1999: Regions Positively Correlated with Pain Threshold
// Subjects=12
7.83	8.06	43.12
57.72	20.25	3.61

// Tolle T R, 1999: Regions Positively Correlated with Pain Intensity
// Subjects=12
-5.18	-35.71	1.22
10.09	-44.51	37.47

// Tolle T R, 1999: Regions Positively Correlated with Pain Unpleasantness
// Subjects=12
-5.05	-4.76	29.85

// Tracey I, 2000: Positive regions of activation common to noxious cold and 
// noxious heat stimulation
// Subjects=6
30.81	58.7	-6
40.46	49.25	-5.32
50.15	43.47	1.75
43.79	24.14	0.1
1.46	5.11	46.79
57.79	8.88	7.91
50.38	-10.2	9.59
61.07	-10.13	9.46
-41.12	-46.16	48.23
34.86	-37.99	64.51
-68.03	-45.03	23.91
11.07	-34.44	29.92
43.79	10.94	-5.49
-41.69	20.46	1.39
27.89	8.96	11.59
-21.39	0.78	-7.23
4.43	-10.47	10.14
7.68	-16.54	13.96
14.07	-29.96	4.97
14.03	-27.05	1.39
-1.84	17.26	39.11
-1.84	17.26	39.11
-11.54	16.44	29.26
1.51	-30.56	39.74
-8.03	-29.84	49.83

// Veit R, 2002: Acquisition, HC
// Subjects=7
57	12	-6
48	21	-12
-57	9	-3
0	9	33
45	48	0
-60	-24	15
63	-15	18
-6	3	66
18	-3	-21

// Veit R, 2002: Extinction, HC
// Subjects=7
3	9	33

// Casey K L, 2001: Heat Pain, Early Phase
// Subjects=14
-1.74	0.77	46.07
-16.57	-4.55	61.19
0.12	27.62	21.49
-48.23	51.97	-3.41
-34.22	25.88	1.96
52.47	1.36	7.48

// Casey K L, 2001: Heat Pain, Late Phase
// Subjects=14
-40.51	2.92	8.42
-28.73	-12.16	5.09
-34.07	-14.3	5.33
-24.02	-11.99	61.9
-5.02	3.33	38.09
-38.22	-17.45	20.14
-7.32	-63.27	-10.94
2.22	-54.12	-17.4
-53.09	-.13	38.93
-14.78	-23.53	8.11
23.65	-13.79	6.85
9.78	-18.1	7.37
23.59	-63.85	-21.29
38.5	4.91	-.46
52.65	-16.47	24.59
11.99	6.89	27.56

// Derbyshire S W G, 1998: Noxious vs. Non-Noxious Tonic Heat
// Subjects=12
18.31	-61.09	-12.54
33.13	49.6	13.7
41.62	9.53	-9.81
-41.45	-18.87	15.83
7.57	-19.94	-2.48
-22.35	6.28	9.04
7.61	24.41	20.56
-.71	-19.37	33.25
-17.92	-62.39	1.37
22.7	-57.58	4.96
-30.7	17.09	39.46
11.87	55.07	31.32

// Hui K K S, 2005: Deqi + Pain, Activations
// Subjects=4
27.67	-20.82	-29.4
2.25	26.41	19.34
2.38	11.32	30.64
-.77	-4.65	30.9
2.49	2.57	41.41
-.72	2.47	40.34
4.65	-43.37	25.17
0.35	-40.31	23.84
49.03	14.35	-16.99
9.61	65.83	19.3
-4.33	65.24	12.82
-3.43	22.86	-26.02
22.48	5.95	0.75
61.21	-22.94	22.8
-61.72	-18.56	21.62
52.88	-41.62	43.42
4.77	8.44	62.08
-2.64	-4.03	66.56
0.16	-65.34	-10.86
-14.51	-64.63	27.17
14.06	-88.32	-20.24
-11.6	-91.9	-22.99
-11.63	-84.5	-23.61
7.47	-77.04	-38.96
12.59	-59.52	-60.56
36.25	-34.77	-31.68
47.02	-48.02	-25.11
37.55	-78.49	-19.11
-42.68	-76.48	-27.27
-33.3	-49.25	-47.51
-30.14	-43.14	-51.4

// Salomons T V, 2004: Controllability Manipulation (UC - C)
// Subjects=16
2	38	-2
-14	40	10
40	-16	12
-44	-16	12
56	-12	12
-64	-16	16
22	-6	-20
-24	-6	-18
-18	-8	-22
-22	-16	-22
-8	-12	4
2	-38	-16
26	52	0
-42	36	12
-28	34	42
-36	-28	58
0	-52	-20
-10	-52	-50
-22	-56	-34
-10	-48	-30
14	-62	-42
10	-54	-30

// Salomons T V, 2004: Stimulus - Controllability Overlap [(UC and C) and (UC 
// - C)]
// Subjects=16
4	8	32
-10	6	34
40	8	-6
-36	6	8
-54	8	-2
8	10	58
-32	-56	-28

// Gu X, 2007: Rating Painful Pictures vs. Counting Neutral Pictures
// Subjects=12
-5.12	29.01	26.25
-2.74	27.39	43.18
46.5	41.67	9.55
-48.83	49.25	-7.51
41.96	25.75	-11.21
19.31	21.63	-8.18

// Gu X, 2007: Rating Painful Cartoons vs. Counting Neutral Cartoons
// Subjects=12
12.14	36.52	25.21
-.52	30.04	48.48
58.4	37.46	9.76
-53.75	-70.85	5.58
-47.97	-40.61	41.71
-21.78	-63.73	57
-64.21	-19.08	43.22

// Gu X, 2007: Rating vs. Counting Painful Pictures
// Subjects=12
-5.22	31.58	19.27
8.2	26.23	53.19
42.34	45.03	22.73
39.73	20.87	-17.41
20.61	11.18	6.28

// Gu X, 2007: Rating vs. Counting Painful Cartoons
// Subjects=12
-.97	44.15	15.71
-2.65	36.83	52.33
-48.56	-53.79	-7.4
-64.24	-19.29	41

// Frankenstein U N, 2001: Cold Pressor Test vs. Rest
// Subjects=12
12	28	22
-8	10	32
0	24	20
52	-26	24
62	-18	20
40	0	18
34	12	12
28	-12	18
-34	50	14
-58	-12	38

// Frankenstein U N, 2001: Cold Pressor Test Masked By Verbal Attention
// Subjects=12
-2	22	20
10	26	20
-30	20	16

// Frankenstein U N, 2001: Distraction vs. Rest
// Subjects=12
12	30	28
-6	20	30
-30	46	10
-36	14	28
-48	20	16
20	4	14
16	-6	16
-38	-62	44
-24	-50	40

// Frankenstein U N, 2001: Cold Pressor Test - Distraction
// Subjects=12
-12	0	34
14	-12	34
52	-22	24
-52	-24	30
-60	4	22

// Frankenstein U N, 2001: Distraction - Cold Pressor Test
// Subjects=12
12	30	26
-6	26	30
4	-40	36
4	12	14
-40	22	32
-28	-54	46

// Stoeter P, 2007: Pain Application I vs. II, Normals
// Subjects=17
-10	52	24
-26	-46	-4
-4	-10	34
-24	-24	34
16	52	28
34	30	-14
56	34	8
30	-16	-10
12	-2	36
28	-20	38

// Stoeter P, 2007: Pain Application I vs. III, Normals
// Subjects=17
-54	6	18
-14	-14	14
-36	-80	-42
48	42	-2

// de Leeuw R, 2006: Painful Heat vs. Continuous Warm Stimulus
// Subjects=9
35.31	42.38	16.51
50.45	10.29	26.83
58.02	-23.84	25.15
51.27	11.07	-4.47
38.51	12.65	3.35
-35.24	12.12	3.13
2.5	5.92	43.36
5.39	37.8	15
0.04	37.77	15.07
7.58	-1.19	5.98
9.78	-14.76	9.32
-11.59	-14.88	9.58
-35.79	-19.89	57.12
-36.26	-66.5	-22.61
4.87	-71.86	42.05
13.21	-79.41	12.48

// Petrovic P, 2000: Main Effect of Pain
// Subjects=7
49.36	-23.17	50.65
44.55	-15.87	14.15
-63.53	-5.62	14.98
16.46	14.64	20.58
-9.59	29.02	15.12
-9.31	2.62	31.17
40.15	-9.92	9.16
-40	-2.94	-3.61
3.3	-24.06	-2.26

// Mochizuki H, 2007: Itching
// Subjects=14
-16	-4	64
48	8	8
-48	10	4
-38	-14	-4
8	16	36
2	-38	26
-16	4	6

// Mochizuki H, 2007: Itching > Pain
// Subjects=14
-38	-14	-4
2	-38	26

// Mochizuki H, 2007: Pain
// Subjects=14
-4	-2	58
36	10	6
-42	10	-4
-8	10	40
-18	6	4
50	-22	12
-2	-4	6

// Mochizuki H, 2007: Pain > Itching
// Subjects=14
-2	-4	6

// Peyron R, 1999: Attention + Iteration, Pain vs. Non-pain, Activations
// Subjects=12
-35.21	-.82	0.87
-11.61	-10.74	8.12
-35.58	45.93	-27.58
-33.08	58.52	24.86
33.23	13.3	12.28

// Peyron R, 1999: Attention + Iteration + Diversion, Pain vs. Non-Pain, 
// Activations
// Subjects=12
-30.96	9.95	2.14
-15.83	-12.37	14.99
-22.79	41.27	-34.03
-35.18	45.65	23.73
-3	22.92	29.73
33.2	12.96	7.85

// Peyron R, 1999: Attention vs. Diversion, Activations
// Subjects=12
-41.04	-43.1	60.24
-.82	27.84	38.21
48.25	9.68	19.1
5.5	-19.27	6.41
57.18	-39.14	47.63

// Peyron R, 1999: Attention, Pain vs. Non-Pain, Activations
// Subjects=12
-26.68	12.26	4.13
-11.61	-10.74	8.12
-20.67	41.11	-36.27
33.21	17.53	11.92
61.03	9.24	12.3
61.46	-41.23	47.75
1.18	-61.53	-16.76

// Peyron R, 1999: Iteration, Pain vs. Non-Pain, Activations
// Subjects=12
-33.08	3.59	2.7

// Peyron R, 1999: Diversion, Pain vs. Non-Pain, Activations
// Subjects=12
-33.11	12.05	1.99
-9.47	-12.84	8.27
-9.46	20.25	23.34
35.24	20.75	-1.75
71.88	-39.51	14.03
9.68	-64.11	-23.34

// Petrovic P, 2002: Positive Regression on SI Activity, Non-Pain, Minute 1
// Subjects=7
16	-32	62
-50	-24	46

// Petrovic P, 2002: Positive Regression on SI Activity, Non-Pain, Minute 2
// Subjects=7
2	-20	48
-44	-18	60
-2	-22	74

// Petrovic P, 2002: Positive Regression on SI Activity, Pain, Minute 1
// Subjects=7
12	16	-22

// Petrovic P, 2002: Positive Regression on SI Activity, Pain, Minute 2
// Subjects=7
48	-34	20
6	6	36
40	0	-6
20	20	-18
-48	-36	24
-38	2	-4
-22	14	-14

// Petrovic P, 2002: Pain, Minute 2 > Pain, Minute 1
// Subjects=7
36	-8	-10

// Petrovic P, 2002: Pain, Minute 1 > Non-Pain Minute 1
// Subjects=7
-4	-18	-14

// Petrovic P, 2002: Non-Pain, Minute 1 > Pain, Minute 1
// Subjects=7
56	-10	30
-50	-18	46
-52	-32	54

// Petrovic P, 2002: Pain, Minute 2 > Non-Pain, Minute 2
// Subjects=7
42	-12	4
38	-4	-6
22	20	-16
10	-20	-6
-36	0	-4
-22	14	-14

// Petrovic P, 2002: Non-Pain, Minute 2 > Pain, Minute 2
// Subjects=7
0	-22	56
-50	-16	60

// Valet M, 2004: No Distraction, Painful - No Distraction, Non-Painful
// Subjects=7
-18	-14	8
12	-14	6
-30	-28	56
-60	-36	22
56	-26	24
-40	-16	14
34	-14	10
-58	-46	36
50	-56	46
-10	-2	46
-10	8	30
-6	-34	24
-36	50	12
36	52	14
-40	6	6
38	16	-4

// Valet M, 2004: Distraction, Painful - Distraction, Nonpainful
// Subjects=7
-32	-30	58
-40	-16	16

// Valet M, 2004: (Distraction, Painful + Non-Painful) > (No Distraction, 
// Painful + Non-Painful)
// Subjects=7
10	-26	10
-2	-28	-18
-22	-70	28
42	-82	0

// Valet M, 2004: (Distraction, Painful - Non-Painful) > (No Distraction, 
// Painful - Non-Painful)
// Subjects=7
-4	58	-6
-2	-60	24

// Valet M, 2004: Covariation of Cingulofrontal Cortex Only During 
// Distraction, Painful
// Subjects=7
8	-22	12
-20	-32	6
2	-34	-16

// Petrovic P, 2002: Main Effect of Pain (POP +PPL + P) - (WOP - WPL - W)
// Subjects=9
36	-26	14
22	10	8
-30	-20	12
-22	-12	14
4	-6	40
16	-4	12

// Farrell M J, 2006: Pain
// Subjects=10
37.98	-12.51	63.46
50.73	-19.8	50.54
54.93	-16.06	43.49
1.48	11.97	52.9
5.71	7.08	44.34
5.59	16.8	32.38
43.92	2.45	8.6
45.95	12.35	-1.17
35.33	17.38	9.68
-39.49	10.07	4.46
-18.15	-51.59	-24.07

// Farrell M J, 2006: Pain and Thirst
// Subjects=10
50.75	-17.35	54.79
54.91	-14.12	41.09
-60.51	-17.1	40.44
44.41	-27.62	60.19
8.12	-5.49	74.36
1.75	-9.41	79.23
63.23	5.54	19.28
1.38	2.14	35.88
5.76	3.19	49.13
5.37	36.57	12.88
-41.67	-1.37	-5.7
41.48	52	-11.14
54.32	36.93	-14.48

// Singer T, 2004: Pain - No Pain in Self
// Subjects=16
6	3	45
33	9	12
-42	-21	21
-54	-24	27
-42	-9	-9
66	-33	36
-18	-33	75
6	-66	-30
0	12	36
51	9	-3
39	24	-3
-30	9	9
-39	9	-21
-39	-3	-9
45	-33	24
66	-36	15
-27	-39	60
-30	-30	72
27	-60	-18
15	-18	0
3	-6	6
-12	-21	12
-6	-42	-27

// Singer T, 2004: Pain - No Pain in Other
// Subjects=16
0	27	33
-3	12	42
60	15	3
-45	30	-3
-36	12	0
-18	-39	-39
-36	45	-9
42	42	-6
-33	-63	-24
-30	-54	-15
-15	-93	0
42	-63	-24
48	-63	-15
30	-72	-15
18	-93	0
39	-81	15
50	-51	12
-30	57	27
-60	-45	30
39	12	3
33	21	-9
-6	-39	-33
-9	-78	-42

// Singer T, 2004: Pain - No Pain in Self and Others
// Subjects=16
-9	6	42
0	24	33
60	15	3
39	12	3
42	27	-6
-30	9	6
-39	0	18
-48	12	-3
-33	-66	-24
27	-66	-18
-6	-39	-30

// Singer T, 2004: Pain - No Pain in Self with Others
// Subjects=16
-12	6	42
-3	24	33
60	15	6
39	12	3
33	24	-9
42	24	-3
-30	9	6
-39	0	18
-30	-63	-27
-6	-39	-30

// Singer T, 2004: (Pain - No Pain in Self) - (Pain - No Pain in Others)
// Subjects=16
6	6	42
12	0	48
-39	-27	24
-21	-33	75
-30	-24	72
-27	-36	60
0	-3	3

// Singer T, 2004: (Pain - No Pain in Others) - (Pain - No Pain in Self)
// Subjects=16
-21	-90	-3
-27	-90	15

// Singer T, 2004: (Pain - No Pain in Others) correlated with BEES
// Subjects=16
-6	45	21
-3	21	39
-45	15	0
30	-63	-24

// Singer T, 2004: (Pain - No Pain in Others) correlated with EC
// Subjects=16
-9	6	39
-6	42	18
-33	9	6
30	-63	-27
-30	-63	-27
-15	-39	-48

// Schmahl C, 2006: Fixed Temperature > Neutral Temperature, Normals
// Subjects=12
-5.26	-15.7	-1.58
-1.74	10.63	49.71
-53.19	-20.96	17.26
60.14	-19.6	24.77
-34.16	16.62	6.08
-11.67	7.41	8.83
20.31	10.09	-.69
36.38	20.47	8.3
-36.88	-50.88	41.89
53.93	-37.39	43.06
46.19	2.78	26.39
-37.34	43.26	20.61
39.71	34.98	30.46

// Schmahl C, 2006: Individual Temperature > Neutral Temperature, Normals
// Subjects=12
-1.74	10.63	49.71
-52.12	-24.22	16.41
59.08	-19.61	24.78
-30.96	17.69	5.96
-20.26	6.84	2.28
23.52	10.1	-.72
36.37	18.1	5.15
-40.12	-41.38	41.13
34.74	-56.79	41.56
14.46	-64.32	42.42
-46.76	-.95	27.77
52.52	5.22	16.08
-34.2	49.11	13.4
42.72	52.74	12.21

// Carlsson K, 2006: Uncorrelated > Correlated
// Subjects=9
26	48	-4
36	24	2
-30	18	6
28	20	64
-34	8	58
52	18	48
58	18	16
42	12	22
-30	-54	40
46	-48	50
58	-54	18
42	-52	-44

// Carlsson K, 2006: Correlated > Uncorrelated
// Subjects=9
6	52	-2
38	-22	-4
-40	-16	6
54	-14	14
-50	-20	18
-48	-24	62
-54	-36	56
36	-18	-20
-22	-10	-18
6	-86	20
6	-48	-8

// Carlsson K, 2006: Uncorrelated High > Correlated High
// Subjects=9
26	46	-4
-30	26	10
-30	10	0
-36	10	60
24	-16	76
12	-12	54
-4	-26	60
-40	-80	40
-8	-18	-28

// Carlsson K, 2006: Correlated High > Uncorrelated High
// Subjects=9
-36	56	-8
-50	46	-10
42	-2	-14
-44	-6	-12
44	-14	6
-44	-22	10
-16	-14	-20
-12	-80	14
-28	-64	-8
-10	-48	-12

// Carlsson K, 2006: Uncorrelated Low > Correlated Low
// Subjects=9
50	14	52
42	10	24
22	20	60
44	6	40
32	22	-2
48	-54	58
38	-52	50
40	-52	-46

// Carlsson K, 2006: Correlated Low > Uncorrelated Low
// Subjects=9
10	48	0
-60	0	26
-60	-6	24
52	-10	16
-64	-20	30
-52	-22	56
-34	-24	34
-38	-26	60
-40	-16	52
10	-100	22
10	-82	22
-28	-14	-20
38	-16	-18
-10	-52	-20

// Carlsson K, 2006: High > Low
// Subjects=9
-34	24	-12
34	18	-16
-2	52	12
2	38	20
8	16	40
8	6	40
-10	0	42
-10	-16	44
50	26	-6
-50	30	0
36	12	6
-34	10	-4
46	-16	0
-40	-18	-6
42	-22	20
-42	-26	24
-28	-30	64
-42	-26	66
6	-32	-28
10	-24	-10
2	-86	10
-14	-58	-20
16	-46	-18
10	-64	-44

// Carlsson K, 2006: Low > High
// Subjects=9
16	42	-20
-18	48	-18

// Geuze E, 2007: Fixed Temperature > Baseline Temperature, Normals
// Subjects=12
12.76	38.93	1.44
9.9	24.91	40.57
-1.86	24.75	39.6
-10.74	37.73	1.81
-5.01	-46.05	18.81
-1.72	-46.24	29.94
-1.68	-45.81	35.48
4.61	-47.05	18.78
42.19	-52.69	38.9
-43.28	-46.43	44.93
49.56	-10.89	42
51.73	-11.68	45.39
50.41	17.61	25.1
-29.79	32.99	24.73
44.75	47.16	-5.19
53.4	17.6	-2.81
57.76	0.88	0.77
-49.9	-58.47	13.68
-41.72	16.86	-3.89
36.36	20.21	4.97
-29.94	18.24	-.79
25.6	-8.09	-15.95
-30.02	-12.28	-23.88

// Geuze E, 2007: Individual Temperature > Baseline Temperature, Normals
// Subjects=12
9.9	26.05	41.59
-.79	25.9	40.61
-3.92	-52.39	19.33
-4.93	-43	30.82
0.48	-52.23	34.88
8.9	-50.2	19
40.05	-51.65	38.84
-45.46	-45.73	40.44
51.7	-9.82	41.89
42.16	-16.77	49.27
46.18	19.15	31.71
31.89	49.99	-8.63
-30.86	31.92	24.84
45.81	47.16	-5.2
53.41	15.49	-2.63
57.77	-1.24	0.95
-51.23	-.75	3.27
-48.83	-56.26	14.59
-41.72	16.86	-3.89
41.63	17.36	-4.89
3.27	-14.77	-3.98
-17.07	5.63	0.12

// Moriguchi Y, 2007: Painful > Neutral, Normals
// Subjects=14
-10	2	52
-8	14	48
8	-2	36
12	16	42
-32	-34	-38
26	-64	-28
-54	10	32
-50	44	0
-56	14	2
-46	36	14
-42	36	40
-42	50	16
-44	54	-14
-20	56	34
-34	56	20
56	10	32
56	10	26
50	50	-16
54	32	30
52	48	-8
24	72	4
-30	16	8
-40	-10	0
44	24	12
0	-32	0
-10	-20	-16
6	-18	-22
-2	-38	-42
-40	-50	58
-34	-36	48
-60	-28	42
36	-46	58
52	-28	44
-62	-20	22
68	-36	36
62	-20	36
-14	-14	10
16	-6	12

// Eickhoff S B, 2006: Left Anodal, Right Cathodal Stimulation > Rest
// Subjects=11
38	-26	20
60	-6	8
36	-4	-20

// Eickhoff S B, 2006: Right Anodal, Left Cathodal Stimulation > Rest
// Subjects=11
-46	-20	16
-38	-22	20
40	-26	22
-42	-6	-6
-48	-36	26

// Jackson P L, 2006: Pain Related Sites of Activation
// Subjects=18
-6	24	39
6	21	42
33	21	0
-30	18	3
60	12	24
-48	9	3
-21	9	0
15	6	0
-12	-12	0
63	-18	36
-60	-21	33
42	-45	51
-30	-51	54
-36	-48	-39

// Jackson P L, 2006: Self vs. Other
// Subjects=18
42	3	-6
-42	3	-6
-42	-3	12
0	0	36
-21	-15	3
-63	-24	36
66	-27	42
63	-30	27
30	-36	63
-15	-54	66

// Jackson P L, 2006: Others vs. Self
// Subjects=18
51	18	48
48	-57	27
-45	-60	27
-51	-69	39
-12	-60	36
3	-66	39

// Maihofner C, 2007: Acute Pain, Placebo
// Subjects=14
41.82	-26.18	56.98
53.37	-10.99	8.73
-54.57	-23.88	18.19
52.18	-45.83	48.25
-44.32	-42.73	50.21
40.26	17.94	-2.69
-45.69	15.81	7.73
13.94	26.95	25.3
50.14	5.18	40.64
44.89	46.67	27.08
22.1	53.07	-.97
-35.09	24.4	40.79

// Maihofner C, 2007: Mechanical Hyperalgesia, Placebo
// Subjects=14
41.36	-29.86	52.05
30.67	-17.66	56.61
55.17	-24.98	14.79
-54.23	-23.4	20.26
51.57	-46.57	52.55
-43.27	-38.99	48.99
41.27	13.23	2.27
-41.95	13.26	6.01
10.3	22.39	21.7
-1.92	23.11	18.33
1.54	54.93	-5.46
58.65	-2.2	3.58
43.07	48.2	27.75
20.74	52.11	1.81
-35.49	43.24	24.27

// Coan J A, 2006: Threatened - Safe, No Hand Holding
// Subjects=16
5.71	11.48	46.2
-9.09	-2.3	62.03
11.26	-2.81	67.41
-11.91	42.24	-8.59
4.13	47.88	-5.9
35.39	39.89	25.64
-40.28	-.14	37.67
13.67	48.31	-14.97
-37.36	39.75	16.45
40.58	18.58	-2.75
-28.9	22.39	-2.27
9.67	9.31	3.96
-9.42	-.27	19.48
-7.47	5.52	-2.21
30.96	5.32	-8.22
-10.53	-12.76	9.39
2.16	-13	-8.58
4.38	-28.59	-3.95
11.07	-55.3	21.63
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23
54.76	-26.66	16.5

// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Spouse, 
// Threatened
// Subjects=16
-11.91	42.24	-8.59
-7.47	5.52	-2.21
4.38	-28.59	-3.95
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23

// Coan J A, 2006: No Hand Holding, Threatened > Hand Holding with Stranger, 
// Threatened
// Subjects=16
-11.91	42.24	-8.59
-8.11	-25.24	40.52
16.48	-30.38	40.67
33.85	-46.11	69.67
-55.28	-28.12	21.23

// Coan J A, 2006: Positive Correlation between Shock Pain Ratings and 
// Threat-Related Activation
// Subjects=16
40.58	18.58	-2.75
2.16	-13	-8.58

// Botvinick M M, 2005: Painful - Non-Painful Thermal Stimulation
// Subjects=12
6	22	27
-30	-10	28
33	6	11
-24	-3	6
24	4	16
15	7	13
53	-34	24
12	3	58
-30	-74	-29
3	-22	29
42	36	23

// Iadarola M J, 1998: Capsaicin vs. Rest
// Subjects=13
-.94	-56.97	-12.66
1.17	-68.22	-20.66
-26.6	-55.01	-12.53
-13.87	-49.28	-22.08
7.51	-49.15	-22.34
-20.21	-2.5	5.3
-26.67	-9.57	-2.96
24.62	-7.15	-3.75
-26.78	2.43	-12.89
16.01	7.6	-4.89
-.84	16.59	30.24
-9.25	6.99	44.52
5.42	28.28	15.8
41.73	8.44	3.67
-41.63	-7.55	-2.96
-9.02	-54.34	49.66
12.3	-32.72	52.06
-13.38	-13.5	55.21
25.13	-23.84	55.63
50.63	-31.75	33.7
-5.29	-37.96	-14.21
-5.26	-28.82	-6.05
-.99	-17.88	-2.56
7.71	-20.69	15.42
3.4	-12.25	14.76

// Iadarola M J, 1998: Mechanical Allodynia vs. Rest
// Subjects=13
-9.25	6.99	44.52
1.33	6.02	31.1
1.15	28.26	15.85
12.05	-2.37	31.68
7.76	-24.57	20.21
7.75	14.86	34.74
-41.68	5.14	-4.02
41.54	21.87	-15.3
-37.29	10.77	13.3
39.54	3.51	-4.82
-26.66	-20.49	-6.5
-20.19	-17.65	2.11
-24.52	-2.87	0.92
-26.77	0.32	-12.71
-43.45	-28.42	30.04
-50.19	12.12	4.41
37.91	-48.4	39.7
-39.19	2.24	40.8
39.41	48.27	-4.11
-35.49	44.68	-16.33
22.94	-9.05	54.42
22.19	51.37	-17.55
-37.54	41.12	-7.08
41.47	40.91	-16.9
-7.18	32.72	46.8
42.09	-23	37.52
33.63	-28.71	47.02

// Iadarola M J, 1998: Mechanical Allodynia vs. Light Brushing
// Subjects=13
-31.24	51.05	-16.91
30.76	47.19	-17.3
17.92	51.34	-17.5
20.13	49.92	-8.49
39.41	46.15	-3.93
-49.98	-16.46	20.19
-28.76	-57.48	-16.76
3.4	-12.25	14.76
-47.97	-9.02	6.16
-32.94	0.56	18.57
37.63	-20.51	15.06
-26.65	-22.6	-6.33
18.32	-47.71	-4.74
33.61	-24.48	46.67

// Jackson P L, 2005: Painful Stimuli vs. Neutral Stimuli
// Subjects=15
-42	-44	56
40	-50	56
8	26	40
-10	18	44
18	2	6
-18	2	4
-42	14	-4
32	18	6
-24	-72	-28
42	-66	-34
12	-70	58
-26	-72	38
58	16	24
-64	16	14
42	44	26
-44	42	10
8	18	52
56	-54	-14
-52	8	32
-28	0	52

// Kulkami B, 2005: Interaction Between Pain and Unpleasantness
// Subjects=17
6	32	-8
-4	34	2
4	38	-22
-4	50	-20
-32	68	6
20	-4	-21
-4	-2	-8
-55	-8	45
-42	-26	16

// Kulkami B, 2005: Interaction Between Pain and Localization
// Subjects=17
39	-30	51
46	-54	58

// Kulkami B, 2005: Correlation Analysis with Affective Unpleasantness Ratings 
// of Noxious Stimuli
// Subjects=17
4	30	20
-4	30	20
-52	10	45
6	-12	-20

// Cheng Y, 2007: Needle > Fixation, Experts
// Subjects=14
-46	-76	-12
22	-26	-8
-22	-26	-12
44	6	30
-52	4	44
38	-52	52
-32	0	66

// Cheng Y, 2007: Needle > Fixation, Normals
// Subjects=14
-50	-66	-14
46	16	-2
2	-42	-2
46	26	22
-62	-26	28
48	8	40
-38	-4	60
-41	-43	60
-2	15	41

// Cheng Y, 2007: Pain Intensity, Positive Correlation
// Subjects=14
-38	10	-4
-44	20	4
46	6	38
4	8	44
-26	-52	68

// Cheng Y, 2007: Unpleasantness, Positive Correlation
// Subjects=14
-52	-38	16
46	6	38
4	6	46
-34	-30	66

// Cheng Y, 2007: Pain Intensity, Negative Correlation
// Subjects=14
0	62	4
-24	-84	-8
26	22	56

// Cheng Y, 2007: Unpleasantness, Negative Correlation
// Subjects=14
-26	-84	-8
16	38	46
-8	60	2

// Cheng Y, 2007: Pain Intensity, Positive Correlation, Normals
// Subjects=14
26	28	-8
-10	-78	8
38	-14	14
42	-2	42
-40	-22	60

// Cheng Y, 2007: Pain Intensity, Positive Correlation, Experts
// Subjects=14
-48	24	2
44	-16	18
-48	-20	20
40	-16	40
58	-22	54

// Cheng Y, 2007: Unpleasantness, Positive Correlation, Normals
// Subjects=14
-6	-76	12
-40	22	16
36	-16	18
-50	-18	32
-2	4	42

// Cheng Y, 2007: Unpleasantness, Positive Correlation, Expert
// Subjects=14
-10	-90	22
16	-82	26
40	-16	40
56	-24	48

// Cheng Y, 2007: Pain Intensity, Negative Correlation, Normals
// Subjects=14
-42	-86	8
-30	-64	62
-2	-54	64

// Cheng Y, 2007: Pain Intensity, Negative Correlation, Experts
// Subjects=14
42	-88	4
-34	-84	12
16	60	6
-30	-56	56
22	-50	58

// Cheng Y, 2007: Unpleasantness, Negative Correlation, Normals
// Subjects=14
-42	-82	6
32	-86	10
-42	40	32
30	-60	58
-32	-62	62

// Cheng Y, 2007: Unpleasantness, Negative Correlation, Expert
// Subjects=14
16	-30	-6
14	58	6
44	-66	4
18	50	42

// Lamm C, 2007: Observation of Patients Expressing Pain and the First-Hand 
// Experience of Pain
// Subjects=17
-52	-2	-16
-38	2	-20
-48	-8	-12
0	6	62
0	14	50
42	-2	-18
34	18	6
-38	18	4
-36	26	4
-32	26	-10
50	-44	18
40	-42	4
-10	12	40
44	20	-16
50	6	-14
22	10	-16
26	0	-22

// Lamm C, 2007: Imagine Self > Imagine Other
// Subjects=17
-52	-26	26
-60	-34	24
42	8	-2
-16	-4	14
-30	2	8
-36	8	4
8	0	54
46	-14	56
22	-32	66
-38	-10	-12
-36	36	34
-60	8	2

// Lamm C, 2007: Imagine Other > Imagine Self
// Subjects=17
26	-76	56
38	-68	56
24	-66	64
48	-64	44

// Lamm C, 2007: Empathy Quotient, Other
// Subjects=17
26	0	10
-36	-2	12
0	-4	42
-22	-46	-24

// Lamm C, 2007: Empathic Concern Index, Other
// Subjects=17
14	16	28

// Lamm C, 2007: Emotional Contagion, Watching Pain
// Subjects=17
30	16	12
44	18	8
-32	-10	10
16	-26	42
6	-4	52
50	-14	44
64	-38	34
-50	-42	36
-56	-44	56

// Chandrasekhar P V, 2008: Activations in Response to Regret
// Subjects=30
9	-81	51
-6	-63	66
-30	-81	39
45	-72	36
-6	-27	12
-54	-66	-18
-21	6	66
3	54	-24
-9	60	-6
0	60	-9
3	-21	72
21	-18	75

// Chandrasekhar P V, 2008: Activations in Response to Rejoice
// Subjects=30
45	15	-12
39	-15	-6
-45	6	-6
-30	-12	15
15	-84	3
-18	9	-9
18	9	-9
63	-27	42
-12	-87	0
3	36	3
-21	-27	-3
12	15	0
-9	36	48
3	-15	-12
33	-60	-12
48	45	24

// Chandrasekhar P V, 2008: Activations in Response to Regret and Rejoice
// Subjects=30
48	21	-18
51	39	-15
-48	18	-12
-6	-75	45
3	-30	27
42	-54	57
-42	-54	57
-3	24	36
63	-39	-6
6	24	63
24	6	-15
51	12	42
9	-3	12
-42	-66	-27

// Schiller D, 2008: Shock > No Shock
// Subjects=17
-9.55	4.96	4.55
13.96	6.25	5.28
-26.64	-1.57	4.18
26.7	4.32	-6.97
-45.91	7.74	2.5
49.18	9.29	0.16
10.77	-11.21	0.09
6.59	-11.35	12.42
-6.41	-12.17	-10.78
-6.39	-24.05	-13.13
3.53	8.84	39.76
1.6	-2.24	61.9
-9.09	-37.51	47.14
5.97	-54.97	54
16.08	-44.44	-17.25

// Seifert F, 2009: Normal Pin-prick Pain, Placebo Administration
// Subjects=12
-56.37	-20.73	20.62
54.77	-25.43	18.62
-42.47	-24.96	19.7
35.26	11.15	-2.06
-53.23	-.45	21.12
56.84	5.67	21.57

// Seifert F, 2009: Pin-prick Hyperalgesia, Placebo Administration
// Subjects=12
-53.18	-18.68	19.3
52.62	-16.82	20.16
-41.57	4.05	9.45
41.76	7.64	7.08
-7.32	26.86	26.1
5.54	22.88	28.52
-10.48	39.42	37.35
7.7	37.41	37.31
-23.32	34.77	33.43
43.95	29.12	23.1
-19.81	-10.45	53.91
36.66	0.32	36.75
-26.14	-56.82	46.72
37.94	-42.6	45.91
-8.44	-12.12	3.74
11.86	-9.89	3.32
-8.49	-18.18	-5.79
-5.03	-41.82	18.46
8.89	-43.69	20.68

// Seifert F, 2009: Main Effect of Sensitization Across Both Pharmacological 
// Treatments (Hyperalgesia > Normal Pain)
// Subjects=12
-48.81	-25.28	29.84
51.66	-21.17	32.8
-42.67	-1.75	3.26
44.98	-5.29	4.78
-29.92	27.3	6.25
34.2	21.09	2.69
-4.17	39.49	23.89
7.57	38.33	21.63
-5.23	42.82	25.86
9.87	38.91	42.74
-4.02	43.23	44.77
-34	21.59	29.08
37.64	16.9	30.88
-16.61	-6.12	54.63
17.6	-20	50.94
-26.12	-58.84	48.01
32.66	-55.15	49.25
-10.58	-12.22	2.65
9.71	-9.98	2.23
-10.63	-15.99	-4.83
2.52	-39.95	28.25

// Bingel U, 2006: Main Effect of Painful Laser-Stimulation
// Subjects=19
42	-42	48
57	-21	21
63	-51	12
39	-6	0
3	30	39
6	39	9
9	-18	9
18	-3	-15
30	-63	-33
18	12	-3
-54	-42	48
-60	-15	15
-60	-36	12
-39	6	3
-3	18	48
-6	42	12
-12	-9	0
-18	-3	-15
-33	-72	-21
-15	15	0

// Obermann M, 2009: Pain-Related Responses Using Train Pulse and Single Pulse 
// Stimulation
// Subjects=11
1.41	15.21	27.5
-.57	-27.24	32.86
46.32	0.89	-13.31
51.76	-54.13	63.76
53.78	-32.21	57.08
9.93	-14.18	11.22
57.59	28.48	28.59
5.97	23.58	47.89
22.81	7.14	8.89
-37.92	-73.6	-24.67
7.39	-27.94	-21

// Obermann M, 2009: Stimulation Level by Condition Interaction
// Subjects=11
1.41	15.21	27.5
10.53	-24.3	-28.13
26.94	-18.32	-11.08

// Watson A, 2009: Not Informed Low Intensity (Conditioning-Preconditioning) - 
// Informed (Conditioning-Preconditioning)
// Subjects=11
4	-22	42
-6	32	24
-26	52	18
-6	44	34
-2	-32	32
-20	-62	2
-8	-48	16
-8	-58	36

// Watson A, 2009: Not Informed (Post Conditioning - Preconditioning) - 
// Informed (Post Conditioning - Preconditioning)
// Subjects=11
12	38	-12
-24	52	18
-6	44	34
-8	42	-10
-6	32	24
-10	40	-12

// Wiech K, 2008: Brain Responses to Pain, Catholics
// Subjects=12
51	-21	27
48	-33	27
36	6	18
39	-21	3
-54	-33	24
18	-102	15
48	-81	-9
24	-9	-9
-27	3	-12
21	0	-15
39	3	-6
-54	-3	12
57	0	9
33	-30	75
9	-15	54
-18	-45	-27
33	9	-21

// Wiech K, 2008: Brain Responses to Pain, Atheists and Agnostics
// Subjects=12
45	-24	21
-60	-24	21
-48	-33	21
57	6	0

// Wiech K, 2008: (Religious - Non-Religious, Catholics) - (Religious - 
// Non-Religious, Atheists and Agnostics)
// Subjects=12
48	30	6
-6	-21	-27

// Wiech K, 2008: (Non-Religious - Religious, Catholics) - (Non-Religious - 
// Religious, Atheists and Agnostics)
// Subjects=12
0	-15	75
18	-12	75
51	-75	9
-15	-24	78

// Helmchen C, 2008: Thermal Pain > Laser Pain
// Subjects=14
8	-4	42
58	-18	14
48	-22	16
-56	-12	26
-48	-12	12
50	4	4
-54	-20	6
-36	-16	10
0	56	-16
-4	64	4
-4	58	-10
8	-12	54
20	-14	76
26	-44	72
18	-46	66

// Helmchen C, 2008: Thermal Pain = Laser Pain
// Subjects=14
6	16	36
0	10	48
-8	8	46
32	20	4
34	18	6
40	18	-2
46	8	14
-32	10	8
-38	26	-2
-36	0	0
36	4	4
40	-2	-10
40	0	-10
36	8	-16
32	6	-12
46	-18	20
38	-14	18
62	-30	18
50	-14	22
52	-18	18
52	-20	32
50	-24	22
54	-14	14
34	-16	16
-4	-10	-2
-8	-20	6
6	-10	0
10	-10	-4
10	-20	8
10	-22	10
10	6	2
20	10	-12
18	6	2
-12	6	-4
-18	12	-8
-20	8	0
-20	6	-10
28	-2	52
28	-2	54
-28	-6	50
-30	-2	58
44	-2	56
-50	4	46
36	0	60
-40	48	22
54	6	26
-56	6	38
-60	12	30
-58	8	18
48	-32	48
34	-40	46
36	-48	54
-56	-38	24
22	-52	0
16	-38	-6
-6	-28	-8
-4	-30	-26
8	-30	-6
6	-36	-36
4	-28	-26
-4	-42	-18
14	-78	-24
-10	-70	-24
-44	-50	-38
-36	-50	-36
-36	-46	-44
-20	-38	-30
-14	-46	-24
-28	-56	-32
-58	-18	30
-22	-10	62

// Kong J, 2006: High Pain > Low Pain
// Subjects=16
14	-42	72
66	-22	22
-66	-26	20
4	2	46
20	-70	-2
36	-20	16
-36	-16	14
-52	10	-4
-32	0	2
-14	-8	8
16	-14	8
0	-48	-26
-8	-78	18

// Kong J, 2006: Pain Intensity Evaluation > Target Matching
// Subjects=16
-28	52	16
-30	20	8
-12	16	56
-14	74	52
-32	-80	34
42	14	2
36	32	4
14	-98	-6

// Maihofner C, 2006: Heat Pain Stimulation - Non Painful Stimulation
// Subjects=14
-34.75	-20.14	53.78
-31.56	-17.04	52.37
-30.38	-58.7	50.27
38	-51.86	50.03
-43.6	-20.11	13.73
56.85	-20.56	12.62
-47.77	-24.48	26.41
52.89	-34.85	48.43
-41.4	11.4	35.6
48.35	7.36	30.45
-38.51	46.54	8.08
42.87	38.88	25.64
-2.73	14.74	61.64
8.88	30.96	50.11
-28.82	22.11	7.79
38.49	20.14	3.84
-2.9	15.23	40.41
5.63	12.91	37.16

// Maihofner C, 2006: Impact Pain Stimulation - Non Painful Stimulation
// Subjects=14
-33.67	-18.91	55.9
-41.23	-5.55	50.4
51.68	3.21	45.25
-30.37	-59.67	51.47
36.95	-58.21	50.57
-54.27	-22.11	16.25
17.34	-20.46	17.52
-50.99	-24.67	24.24
59.27	-40.61	42.15
-50.17	15.64	8.58
52.54	9.79	20.16
-29.78	29.82	25
39.62	42.84	22
-4.95	25.93	55.15
8.92	25.84	52.77
-48.06	15.31	4.12
41.73	13.99	6.55
-48.06	15.31	4.12
40.83	-20.57	13.92
-.84	26.44	33.87
4.55	12.73	34.96

// Maihofner C, 2006: Impact Pain Stimulation - Heat Pain Stimulation
// Subjects=14
-54.27	-23.26	15.23
60.06	-18.26	14.62
-49.89	-31.98	25.95
52.68	-25.02	24.19
54.68	10.95	21.15
-31.83	-23.12	14.97
36.39	26.01	11.18

// Mohr C, 2008: Pain vs. High Level Baseline
// Subjects=17
2	16	56
6	22	40
-4	22	40
40	46	6
-38	36	14
-38	32	24
-42	50	20
36	46	-16
46	-44	48
54	-42	54
42	-48	40
-38	-54	46
-20	-42	76
-60	-24	22
-54	-18	10
-64	-16	12
-44	-22	12
52	-4	8
-52	-4	4
-32	20	-4
34	24	-8
32	16	8
-38	-18	14
14	14	-2
-14	14	-4
-40	-58	-34
-44	-74	-30
38	-74	-28
-8	-80	-32
-10	-74	-46
-20	-72	-46

// Mohr C, 2008: Self Administrated Thermal Stimulation vs. Externally 
// Administrated Thermal Stimulation
// Subjects=17
52	-4	8
-38	-2	-14
60	2	8
36	-20	56
28	-14	60

// Mohr C, 2008: Externally Administrated Thermal Stimulation vs. Self 
// Administrated Thermal Stimulation
// Subjects=17
32	56	30
42	52	8
4	-58	-32
0	-48	-18
0	-46	-6
-6	-62	-32
-8	-50	-16

// Mohr C, 2008: Externally Administered Thermal Stimulation = Self 
// Administered Thermal Stimulation
// Subjects=17
0	16	44
8	14	44
4	10	54
36	18	4
42	12	-4
38	10	-6
-32	14	6
6	-66	-16
8	-76	-18
-4	-58	-12
26	-60	-24
22	-52	-24
-28	-50	-30
-28	-60	-28
-22	-66	-24

// Zaki J, 2007: Self Pain + Other Pain, Common Activations Assessed by Masked 
// Contrast Analysis
// Subjects=13
46	28	20
4	10	40
48	8	40
42	22	-12
28	28	2
28	16	6
30	20	-2
12	-2	10
20	-6	14
16	-10	20

// Seymour B, 2004: Temporal Difference Prediction Error
// Subjects=14
32	0	-8
-30	-2	-4
18	20	6
-10	-10	-8
46	22	-4
28	-46	-30
-34	-52	-28

// Seymour B, 2004: Temporal Difference Value
// Subjects=14
42	16	-14
0	-28	-18
8	12	32

// Mobascher A, 2010: Activation in Response to Laser Stimulation
// Subjects=20
52	-24	22
60	-44	34
38	22	-2
30	-38	62
26	0	-22
32	-12	62
36	48	18
-64	-20	20
-36	22	0
-64	-24	22
6	12	36
14	-70	38
-14	-46	-34
10	-4	0
-10	-10	4
-6	-14	-20
-6	-20	-28

// Tseng M T, 2010: Innocuous Heat vs. Reference Temperature
// Subjects=12
-52	-40	40
58	-34	40

// Tseng M T, 2010: Noxious Heat vs. Reference Temperature
// Subjects=12
-64	-26	18
58	-24	22
-36	-20	6
38	-2	6
-14	-44	64
48	2	48
10	-18	-12

// Tseng M T, 2010: Noxious Heat > Innocuous Heat
// Subjects=12
-30	34	10
40	54	14
48	18	30
-40	14	-8
-52	8	22
26	10	-20
50	12	22
54	18	18
-34	16	6
36	16	2
-18	-62	-26
36	-52	-38
-14	-6	72
10	16	56
-4	-30	70
-14	-8	6
10	-6	8
-6	2	40
-4	4	42
2	2	44
2	20	32
-30	-18	8
20	10	-10
-6	-18	-14

// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued)
// Subjects=10
58.15	-33.48	38.22
-59.5	-25.43	28.86
57	6.33	43.82
-37.03	-4.09	41.31
-3.88	8.42	48.8
6.83	8.74	52
4.57	6.39	35.49
-3.91	10.28	45.3
41.72	16.1	6.37
-37.33	20.28	12.5
25.7	8.35	3.86
-23.5	13.08	0.68
15.1	-8.38	8.73
-10.58	-9.93	4.69
-67.2	-10.19	6.48

// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued), Pain Expectancy 
// Sensitivity as Covariate
// Subjects=10
36.38	51.19	20.22
9.01	-8.34	51.17
55.05	-14.86	59
2.39	-79.79	-5.21
28.63	3.34	-33.67
-30.13	2.01	-31.77
27.77	-16.53	-15.27
-27.72	-30.27	-9.02
0.93	-27.84	-35.2
36.34	-65.61	-31.32

// Ziv M, 2010: Pain (Cued + Uncued) >  Warm (Cued + Uncued), Harm Avoidance 
// as Covariate
// Subjects=10
3.51	18.53	41.18
-.77	20.61	41.05
-8.31	18.91	33.47
3.79	0.58	70.56
-.48	0.55	70.61
42.29	-22	64.2
11.15	-53.39	32.62
-4.92	-40.71	32.86
-44.45	-71.67	21.41
-37.66	-1.8	-39.17
7.61	-5.25	8.55
25.74	-18.69	-1.68
29.83	-8.49	-21.54
-24.66	-7.67	-19.87

// Brooks J C W, 2002: Right Attend vs. Baseline
// Subjects=18
39.93	21.26	-1.77
-31.37	27.6	1.06
-40.74	-17.89	20.29
72.73	-12.92	21.23
-66.61	-19.79	24.28
62.57	10.08	-7.77
-60.53	-1.95	-3.36
7.9	21.82	28.98
-8.24	16.76	33.12
1.52	-15.74	29.44
26.84	-65.07	-28.86
-38.07	-65.92	-34.39

// Brooks J C W, 2002: Right Visual vs. Baseline Visual
// Subjects=18
43.25	12.01	2.45
-57.18	-1.11	5.46
-43.98	-17.9	20.35
69.56	-28.78	23.97
-66.67	-23.5	19.05
59.3	10.92	-10.04
7.89	25.01	28.66
-4.94	10.7	37.02
23.75	-59.58	-15.9

// Brooks J C W, 2002: Left Attend vs. Baseline
// Subjects=18
46.25	22.27	-14.3
-38	25.37	-10.93
-37.88	14.29	-3.11
46.76	-14.39	18.45
62.61	11.45	-4.54
11.21	25.65	35.27
-1.79	25.29	32.16
-18.4	-74.07	-19.35
-57.15	-4.19	6.89
43.36	48.98	18.96
-28	41.72	14.17

// Brooks J C W, 2002: Left Visual vs. Baseline Visual
// Subjects=18
39.95	14.88	-1.14
-37.78	11.72	3.86
49.92	-11.7	12.53
66.23	-19.63	18.64
62.58	7.95	-7.56
-60.55	4.43	-3.99
4.68	28.5	31.73
8.02	13.94	36.48
-1.7	10.71	36.96
-31.14	55.61	25.18

// Mobascher A, 2009: Activation in Response to Laser Stimulation
// Subjects=12
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
24	0	20
46	44	2
28	-6	70
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36
12	-14	8
-8	-12	0
-8	-20	-16
0	-30	-48

// Mobascher A, 2009: Electrodermal Activity High vs. Low
// Subjects=12
60	-20	16
58	-42	20
40	4	6
48	-34	60
4	-52	60
46	44	2
-62	-22	20
-34	-20	14
-62	-40	28
2	10	40
-34	-52	-36

// Rottmann S, 2010: Pre-LFS vs. Rest
// Subjects=17
44.07	29.81	-13.89
60.36	12.95	-11.38
69.7	-13.5	38.14
69.37	-12.7	12.3
39.85	18.51	-8.22
61.01	-27.02	31.79
48.65	-2.21	-.71
61.16	-24.81	43.89
-46.4	-9.99	1.68
-66.41	-17.17	40.83
-66.7	-12.76	19.1
-58.41	9.76	-4.56
-62.46	17.24	18.3
-62.61	15.03	6.2
-46.7	11.85	-17.29
5.56	38	18.45
-3.1	42.22	18.18
39.9	65.9	5.02
-33.69	34.1	-9.63
-33.6	21.65	-5.04

// Rottmann S, 2010: Post LFS vs. Rest
// Subjects=17
57.03	-44.21	54.85
49.55	-52.33	60.26

// Rottmann S, 2010: Pre LFS - Post LFS
// Subjects=17
65.27	-14.35	29.34
65.11	-12.3	16.81
56.62	-23.2	27
48.9	-12.35	17.09
73.76	-37.35	12.42
-66.41	-17.17	40.83
-66.78	-17.74	11.75
1.62	-9.49	38.91
1.28	17.47	17.2

// Rottmann S, 2010: Post LFS - Pre LFS, Regressed with Sensory SES-S Rating
// Subjects=17
5.38	32.29	3.33
14.04	41.14	5.67
5.67	39.89	27.23
-2.94	31.36	28.22

// Rottmann S, 2010: Post LFS - Pre LFS, Regressed with Affective SES-A Rating
// Subjects=17
5.12	33.61	-16.96
-16.34	21.5	-7.56
-16.34	9.49	-9.73
48.26	49.61	-20.4
52.56	45.06	-23.39
49.28	-46.75	39.54
44.12	21.4	-11.94
48.32	16.13	-22.69
-7.42	42.21	18.26
-41.33	-71.12	47.98
-45.74	-63.04	42.77

// Christmann C, 2007: Pain - Baseline
// Subjects=6
-50.07	-10.8	10.8
-54.26	-19.83	18.29
-44.8	-3.88	3.46
-41.47	-16.84	14.55
-32.02	19.97	8.01
-60.7	7.25	25.02
-43.29	-15.79	55.74
-51.86	-12.76	54.47
-31.54	-22.33	52.81
-47.53	-21.99	58.54
-33.63	-18.57	60.33
-13.44	-21.84	43.64
-15.58	-22.91	43.76
-8.2	-1.98	38.57
-9.29	-2.16	36.37
-2.71	-11.41	53.8
-2.74	-16.07	48.61
-.95	-55.92	-12.75
-2.87	-59.16	14.31
11.3	-5.72	71
10.2	-8.19	66.76
19.27	-51.19	-22.3
21.4	-51.26	-23.43
49.43	-27.67	17.76
53.7	-27.64	17.71
49.2	2.94	0.7
44.88	12.26	-2.27
44.87	6.72	-5.15
53.55	-6.21	5.87

// Christmann C, 2007: Pain - Baseline, Correlation with Pain Intensity Rating
// Subjects=6
-46.8	-16.7	16.83
-50.79	-13.81	54.55
-57.62	-1.67	5.66
-2.72	-14.84	50.74
-49.92	-37.78	19.75
-33.63	-18.57	60.33
-9.25	-2.87	40.89
25.62	-50.7	-30.22
32.07	-62.29	-29.32

// Christmann C, 2007: Pain - Baseline, Positive Correlation with Pain 
// Unpleasantness Rating
// Subjects=6
-47.55	-21.11	56.24
0.54	-15.27	58.54
-30.41	-26.03	59.8
-9.29	-2.16	36.37
30.94	-45.38	-30.73

// Christmann C, 2007: Pain - Baseline, Negative Correlation with Pain 
// Unpleasantness Rating
// Subjects=6
-61.77	8.39	26.05
-46.92	0.68	7.57
-67.11	-14.7	16.89
-14.5	-21.77	44.76
-48.92	-25.34	15.35
12.88	-57.57	-21.69
9.16	-10.14	69.17
60.99	6.61	5.83

// Mobascher A, 2010: Pain > Rest
// Subjects=32
54	-26	20
62	-26	36
38	2	2
52	-20	34
24	0	-20
44	0	58
42	24	-6
-60	-38	22
-36	20	0
-64	-22	22
4	8	36
14	-72	40
-26	-66	-28
10	-16	6
-10	-12	0
8	-18	-18
8	-22	46

// Mobascher A, 2010: Habituation, All
// Subjects=32
54	-26	20
62	-26	36
38	2	2
52	-20	34
44	0	58
42	24	-6
-60	-38	22
-36	20	0
-64	-22	22
4	8	36
14	-72	40

// Mobascher A, 2010: Habituation, Fast
// Subjects=15
54	-26	20
62	-26	36
38	2	2
52	-20	34
44	0	58
42	24	-6
-36	20	0
4	8	36

// Vanhaudenhuyse A, 2009: Wakefulness, Non-Painful > Rest
// Subjects=13
-6	-22	-12
-58	-34	12
46	-16	-4
46	-38	52

// Vanhaudenhuyse A, 2009: Non-Painful, Wakefulness > Hypnosis
// Subjects=13
0	-22	-16
-54	-42	8
46	-14	-6
48	-36	52

// Vanhaudenhuyse A, 2009: Wakefulness, Painful > Rest
// Subjects=13
0	-22	-14
6	-18	16
-14	10	8
16	6	-2
-60	-34	10
40	-14	14
48	-34	52
-6	18	44
34	48	12
36	14	60

// Vanhaudenhuyse A, 2009: Painful, Wakefulness > Hypnosis
// Subjects=13
8	-18	14
10	-18	14
-14	12	10
18	8	2
-54	-40	6
34	-14	12
46	-40	52
-4	24	46
36	50	12
36	6	54

// Vanhaudenhuyse A, 2009: Wakefulness > Hypnosis, Painful > Non-Painful
// Subjects=13
4	-10	12
24	2	-6
-20	8	6
4	12	58

// Wiech K, 2006: Main Effect of Pain
// Subjects=12
57	0	3
-39	-18	15
-42	3	-9
-36	0	9
-54	-18	12
-15	6	0
15	6	-3
12	9	15
-51	-24	27
51	-45	33
51	42	-9
24	30	-15
-24	39	-9
-21	21	-6
-57	-42	36
0	31	2

// Wiech K, 2006: Externally-Controlled - Self-Controlled
// Subjects=12
27	30	-15
45	33	-12
27	45	0
-45	33	-15
-27	30	-15
-15	45	-15
-54	-21	-24
9	33	3
15	-87	-36
-3	45	36

// Wiech K, 2006: Self-Controlled - Externally-Controlled
// Subjects=12
9	12	54
-3	15	48
-9	12	42
33	33	39
30	42	42
39	39	39
27	51	33
45	45	30
48	51	12
-39	54	21
-12	-6	63
-48	-36	45
45	-36	54
54	-33	33
48	-33	45
-45	-27	21
51	6	12
-60	-30	21
-36	12	9
-12	27	51
15	-66	-12
27	-60	-24

// Wiech K, 2006: Self-Controlled - Externally-Controlled, Correlated with 
// Belief in Self-Control
// Subjects=12
36	48	21
33	57	15
24	18	60
-15	-96	0
-45	-72	-21
42	-72	9
-6	-18	69
27	-21	63
15	-66	66
-6	-24	33
-12	-27	9

// Alkire M T, 2004: Stimulus Intensity Encoding
// Subjects=6
-40	-20	12
-52	-22	18
-44	-34	62

// Alkire M T, 2004: Pain Intensity Encoding
// Subjects=6
-54	-22	20

// Alkire M T, 2004: High-Pain Encoding
// Subjects=6
2	12	32
4	10	68

// Freund W, 2007: Right weak - rest
// Subjects=15
-54	-16	18
52	30	22
62	-12	22
56	-52	46
-30	54	4

// Freund W, 2007: Left weak - rest
// Subjects=15
56	-18	12
38	-4	-8
42	0	8
-56	-16	36
14	-68	54

// Freund W, 2007: Right moderate - rest
// Subjects=15
42	50	10
-40	40	-4
50	-42	52
-46	-56	48
0	38	36

// Freund W, 2007: Left moderate - rest
// Subjects=15
44	52	12
56	-22	54
56	-20	14
56	-30	48

// Freund W, 2007: Right pain - rest
// Subjects=15
54	-54	48
-40	-16	16
38	44	-6
40	14	-6
-4	4	18

// Freund W, 2007: Left pain - rest
// Subjects=15
38	52	2
46	0	8
42	-28	10
-54	6	-2
36	6	38
-24	-42	2

// Freund W, 2007: Right increase
// Subjects=15
54	-54	48
46	46	4
-2	-2	22
-4	8	12
-38	-12	6
-40	-16	14

// Freund W, 2007: Left increase
// Subjects=15
42	50	-2
56	22	26
46	0	10
-52	18	-12
10	28	48

// Freund W, 2007: Right tonic pain early - rest
// Subjects=15
20	-34	12
32	-52	2
12	10	16
2	16	72
32	18	-2
-44	-4	8
40	52	20

// Freund W, 2007: Left tonic pain early - rest
// Subjects=15
14	-22	18
8	20	0
64	-18	20
-24	-48	6

// Freund W, 2007: Right tonic pain late - rest
// Subjects=15
-22	18	34

// Freund W, 2007: Left tonic pain late - rest
// Subjects=15
62	-18	18
54	-18	54
18	26	36

// Freund W, 2007: Left tonic pain late - tonic pain early
// Subjects=15
38	-10	14
-32	34	12

// Freund W, 2007: Right tonic pain early - tonic pain late
// Subjects=15
-6	18	6
8	-56	64
22	-34	12
6	28	-6

// Freund W, 2007: Left tonic pain early - tonic pain late
// Subjects=15
-4	12	4
26	-50	72
-16	-52	64

// Freund W, 2009: Right weak - rest
// Subjects=15
0	-64	-34
26	-12	70
-14	-78	-26
8	-20	6
26	22	-12
40	50	-10
26	-34	58
34	-24	42
10	8	30
12	4	62
36	18	-12
28	-18	-8
-36	18	-8
18	4	52

// Freund W, 2009: Left weak - rest
// Subjects=15
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
54	-52	4
-24	-64	48
16	-72	42
-34	-32	50
-38	-22	64
34	-70	40

// Freund W, 2009: Right moderate - rest
// Subjects=15
28	-12	66
46	36	34
36	60	-4
34	24	-6
42	-60	46
2	22	50
-30	18	0
58	12	26

// Freund W, 2009: Left moderate - rest
// Subjects=15
-44	-32	6
38	-62	54
48	32	26
42	-2	28
40	52	-12
16	-66	64
54	-52	4
-24	-64	48
-34	-32	50
14	30	26
-18	-86	18
66	-30	6
14	-78	22
14	-86	10
-36	54	-4
46	-40	46
12	24	58

// Freund W, 2009: Right pain - rest
// Subjects=15
26	10	-8
-34	26	0
12	24	46
-12	-80	-36
22	-12	68
-10	-8	-10
54	16	0
20	8	58
0	-2	12
-60	10	10
36	48	28
38	54	-2

// Freund W, 2009: Left pain - rest
// Subjects=15
44	24	-4
50	24	28
42	-62	54
12	24	48
56	-36	44
-36	38	22
-34	-20	64
-32	-44	36
-22	-84	-50
-40	-2	8
-40	52	-6
-38	-68	-50
-52	-24	20
-60	6	4
-8	-82	-34
56	-46	0
12	10	66
42	36	36
36	46	22
22	56	20
-42	-36	38
-32	24	12

// Freund W, 2009: Right increase
// Subjects=15
18	-10	62
-32	26	-2
34	24	-4
-4	26	42
52	14	-2
-60	10	10
-12	2	8
48	40	18
16	2	6
26	10	-8

// Freund W, 2009: Left increase
// Subjects=15
44	-62	52
52	24	28
44	24	-4
-20	-86	-48
36	46	22
-28	20	58
-8	-4	0
-42	52	-6
56	-36	46
8	26	54
-14	-82	-28
-44	10	-6
40	36	36
-38	38	26
-36	-68	-48
22	10	-8
44	52	-8
-34	-52	48
12	12	68

// Freund W, 2009: Right tonic pain early - rest
// Subjects=15
-16	22	-14
-30	30	2
-60	-24	8
-46	-34	34
20	6	48
-2	10	52
62	-18	14
10	-20	16
-2	-72	-2
42	2	30
52	24	0
46	16	24

// Freund W, 2009: Left tonic pain early - rest
// Subjects=15
-20	-42	70
2	24	44
-32	42	28
40	16	2
52	20	22
-62	-18	22
10	0	10
-56	-36	46
2	8	-2

// Freund W, 2009: Right tonic pain late - rest
// Subjects=15
38	20	-2
12	2	62
44	-62	-38
32	-10	34
-12	-94	16
10	-64	-34
-20	24	24

// Freund W, 2009: Left tonic pain late - rest
// Subjects=15
-28	14	12
-26	42	12
34	20	-22
-34	36	-4
14	6	44
10	4	64
-2	-74	-42
-26	-54	-44
-52	8	4
38	16	2
-12	10	60
52	20	-6
42	42	-12
58	2	8

// Freund W, 2009: Right tonic pain early - tonic pain late
// Subjects=15
-44	-26	-8
6	4	14
-54	-62	-16
-8	22	2
-18	-42	74
-28	-66	48
10	-20	18
-6	12	-12
58	-14	4
-26	-54	46
-8	-70	52
-34	6	-38

// Freund W, 2009: Left tonic pain early - tonic pain late
// Subjects=15
-18	-8	70
-12	-34	76
56	-16	2
-50	-24	4
2	12	2
38	-38	54
-26	-68	48
-4	-70	50
-42	-24	-24
0	-48	62
-56	-68	-6
0	-10	58
-4	-30	52

// Freund W, 2009: Right tonic pain late - tonic pain early
// Subjects=15
-18	30	32
8	-58	-32
26	18	20
-18	-52	-46
30	16	-30
40	42	-16
-30	-16	26
-34	-56	22
36	-12	18
-8	20	54
14	-74	-38
36	-40	-14
34	-82	-46

// Freund W, 2009: Left tonic pain late - tonic pain early
// Subjects=15
30	-10	24
12	-46	-40
-24	-28	-6
32	-26	-14
26	-40	26
-16	-52	-42
-10	-44	24
-20	44	34
14	-72	-42

// Niddam D M, 2002: Nonpainful Activations
// Subjects=10
46	38	13
4	-11	48
51	15	36
51	14	7
40	-26	60
59	-11	16
65	-24	17
42	-22	58
26	-28	68
57	-21	47
46	-54	47
14	-66	42
57	2	5
65	-38	13
0	4	42
44	-13	15
37	-4	-7
14	-14	8
-61	-21	14
-6	-72	46

// Niddam D M, 2002: Painful Activations
// Subjects=10
50	13	20
2	2	48
32	43	14
48	12	36
59	-16	14
65	-22	21
40	-28	60
63	-39	31
16	-62	40
55	2	4
51	10	0
0	15	23
6	12	38
4	-11	47
44	-13	17
38	18	5
40	2	7
38	-2	-8
14	-13	8
-55	4	9
-42	2	9
-59	-19	15
-59	-38	26
-10	-68	37
-50	7	-7
-2	-26	27
-38	-23	13
-42	-4	-6
-38	-18	-6
-13	-15	8

// Niddam D M, 2002: Increases in Painful and Nonpainful
// Subjects=10
63	-22	22
63	-28	25
50	10	0
38	6	-7
46	-15	19
36	2	8
14	-9	10
12	-19	8
-57	-1	9
-8	-70	35
-50	5	-7
-38	-20	-6
-36	6	2
-16	-13	8

// Niddam D M, 2002: Increases in Painful, Decreases in Nonpainful
// Subjects=10
32	42	16
44	10	7
48	-8	-3
0	15	23
12	2	42
10	8	38
2	-30	24
34	16	10
38	-14	-8
-53	-15	14
-59	-37	28
-38	-45	34
-6	-26	29
-44	8	12
-40	1	15
-40	-17	19

// Grabenhorst F, 2010: Regions that Track Pleasantness of Both Temperature 
// and Taste Rewards
// Subjects=12
-28	52	-2
2	44	-2
-6	8	-16

// Grabenhorst F, 2010: Regions that Track Pleasantness for Temperature
// Subjects=12
-32	56	-6
4	38	-2
-2	20	-4

// Grabenhorst F, 2010: Temperature Stimuli Activations Correlated with 
// Subjective Pleasantness Ratings of Temperature
// Subjects=14
52	-20	-28
44	-12	58
-26	48	2
-10	-2	0
64	-14	22
4	4	48

// Grabenhorst F, 2010: Responses to Temperature (Warm and Cold) > Responses 
// to Neutral Control Stimuli
// Subjects=14
50	28	30
40	16	18
10	6	20
18	16	-6
-18	4	14
32	48	-8

// Brooks J C W, 2005: Face
// Subjects=14
-36	24	-6
38	16	2
-38	4	4
40	12	-4
-38	-10	10
-56	-18	14
62	-26	14
-26	4	-8
28	12	-8
44	20	-10
-12	-8	4
16	-10	4
4	-16	4
-14	-16	4
58	-32	20

// Brooks J C W, 2005: Hand
// Subjects=14
-32	22	0
38	16	0
-36	12	0
38	12	2
-38	-16	8
64	-26	14
-22	8	-10
24	12	-6
46	24	-12
12	-8	4
6	-16	-2
-58	-28	14
56	-28	18

// Brooks J C W, 2005: Foot
// Subjects=14
-34	22	-4
38	14	0
-40	8	-2
-38	-18	8
-56	-10	4
-22	14	-6
26	16	-2
46	22	-12

// Yoshino A, 2010: Pain > No Pain
// Subjects=15
-2	8	32
40	-12	8
-38	-12	6
10	-16	10
-8	-20	0
30	-4	-14
60	-20	20
-60	-20	12
34	52	24

// Downar J, 2003: Conjunction: Transient Response to Onset/Offset of 
// Non-Painful and Painful > Non-Painful
// Subjects=10
61.26	-40.03	22
61.06	4.13	14.96
-51.22	5.86	6.07
9.93	8.79	38.57
-2.99	14.29	28.22
0.41	-16.65	40.82
16.2	-15.69	10.44
-6.26	-22.68	4.6
-25.65	-1.36	-7

// Downar J, 2003: Conjunction: Sustained Response to Onset/Offset of 
// Non-Painful and Painful > Non-Painful
// Subjects=10
51.58	-24.22	20.79
-54.2	-28.03	22.32
44.84	15.18	-5.86
-32.02	22.09	7.83
44.92	-.43	-1.2
-38.46	1.99	-3.79
-41.17	-22.47	51.82
0.3	-34.31	18.88
0.41	-3.44	46.4
12.86	-53.43	-23.15

// Henderson L A, 2006: Superficial Pain vs Deep Pain
// Subjects=19
5	50	-4
6	-20	60
-6	-41	52
38	11	4

// Johnstone T, 2012: 49 > 44 C; Modulated by Fit to Pain-Experience Function
// Subjects=14
45.94	13.33	-2.37
-4.26	-14.18	-9.52
6.82	11.91	51.73
4.61	-27.25	27.16
-32.08	16.03	-1.7
60.25	-39.35	30.88
4.58	0.93	33.72
18.16	5.5	-4.74
19.39	-10.38	9.96
27.87	-27.56	-6.54
47.24	-16.13	15.7
-15.91	-12.08	4.93
58.85	-32.92	-9.79

// Birbaumer N, 2005: CS+ vs CS- (differential activation during 
// conditioning), Acquisition, Healthy Controls
// Subjects=10
-36	3	-12
36	12	-15
-3	9	39
-3	33	-3
3	18	39
-24	30	-12
-60	-27	33
51	-42	24
12	3	69
-27	3	-18

// Birbaumer N, 2005: Interaction (CS type X early/late acquisition), Healthy 
// Controls, Early > Late Acquisition
// Subjects=10
27	3	-27
-36	57	-3
0	57	-9

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Contralateral
// Subjects=15
-4.75	-7.13	67.96
-43.24	-24	59.78
-30.35	-19.98	69.33
-27.3	-28.1	46.56
-27.12	-39.5	64.24
1.54	-1.78	54.05
-49.91	-30.03	23.56
-53.32	-2.53	7.91
-27.7	-2.63	4.28
-1.91	-60.35	-1.21

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Block vs. Rest, 
// Ipsilateral
// Subjects=15
4.83	-4.16	64.25
4.66	7.24	46.57
49.56	1.17	46.56
62.45	-24.39	45.21
36.83	-44.09	40.47
62.33	-32.28	25.8
52.43	1.02	3.05
58.91	5	12.68
42.79	0.7	-.16
39.55	16.8	1.88
49.11	39.32	3.22
14.02	-8.47	7.63
13.95	-52.02	-18.82
-21.29	-65.18	-20.66

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Contralateral
// Subjects=15
-4.72	-10.05	71.55
-23.89	-32.63	70.32
-23.92	-19.68	72.58
-23.93	-42.91	61.14
-52.89	-21.14	56.3
-33.67	-31.05	50.22
-1.73	0.86	47.18
-4.88	-8.42	51.34
-11.17	-40.18	54.08
-53.16	-23.97	19.74
-43.68	-2.22	11.12
-40.56	-13	-4.74
-50.23	6.23	-2.9
-14.81	-21.59	5.72
-27.68	-8.98	4.81
1.27	-60.59	-4.58

// Blickenstorfer A, 2009: Wrist Flexion/Extension, Event vs. Rest, 
// Ipsilateral
// Subjects=15
11.29	-3.61	70.82
4.5	22.08	31.95
7.79	13.09	39.35
59.15	-32.04	29.17
33.22	7.76	9.4
36.48	-18.11	4.84
55.68	-1.88	6.6
7.64	-14.86	8.24
13.95	-52.02	-18.82

// Bar K-J, 2007: BOLD signal increase over 37C, 42C, 45C; Healthy Controls
// Subjects=13
-55.85	-17.83	21.66
60.94	-16.59	28.51
71.7	-1.56	27.96
32.27	-15.19	68.08
29.77	28.23	50.38
44.36	41.77	10.7
-50.38	-54.5	19.59
-62.85	-23.93	-20.2
4.07	-27.06	57.41
10.05	-67.98	9.81
31.55	-73.09	-.13
3.93	-84.97	35.13
22.71	-18.78	-4.24
20.56	-36.22	-6.96
24.67	-74.96	-31.21
-35.96	-55.38	-36.59
11.91	-60.37	-12.26
-3.17	-62.24	-8.46

// Landgrebe M, 2008: Controls: Thermal Stimulation > Baseline
// Subjects=15
36	21	3
-33	15	6
-57	3	42
66	-21	24
48	30	33
48	3	36
6	21	48
42	-48	45
30	6	57
-48	-36	48

// Loggia M L, 2014: Healthy Controls: Pain
// Subjects=14
16	-98	-4
-14	-98	2
10	-72	18
22	-82	16
56	-24	20
8	-72	-24
-8	-68	-4
-26	-72	34
-30	-62	-22
-8	-86	0
-54	-26	20
-18	-10	-2
-34	-24	4
6	-14	-12
-12	-18	-2
-24	-2	0
-34	2	2
6	-26	-2
38	22	14
38	8	-12
60	8	16
42	-10	4
46	20	-2
26	-2	2

// Gracely R H, 2002: Controls: Subjective pain control condition (high 
// pressure, high pain)
// Subjects=16
54	-20	44
-52	-22	52
64	-26	22
54	-30	26
52	-52	48
48	-54	38
38	4	0
-48	12	-2
54	16	2
12	2	68
2	2	58
14	4	20
28	6	-2
-12	0	2
12	-8	12
6	-4	6
12	-14	2
-12	-12	6
60	12	-6
-24	-48	-30
-36	-44	-38
-50	-58	-36
28	-70	-32

// Gracely R H, 2002: Controls: Control condition (low pressure, low pain)
// Subjects=16
-46	2	8
54	10	-4

// Gard T, 2012: Practitioners > Controls, Mindfulness vs. Baseline (Receiving 
// shock)
// Subjects=17
49.35	-17.52	11.33

// Gard T, 2012: Controls > Practitioners, Mindfulness vs. Baseline (Receiving 
// shock)
// Subjects=17
46.38	-47.98	30.65
36.21	-43.91	-39.83
29.81	48.47	-.67
17.08	16.41	-1.18
-1.68	-34.81	40.13
-1.51	-36.44	60.34
-14.95	16.48	2.53
-37.44	-73.16	-39.88
-34.35	54.17	-3.76
-31.11	-31.12	-33.44
-30.55	-28.63	39.95
-53.01	-38.8	34.37

// Gard T, 2012: Practitioners, Baseline vs. Mindfulness (Receiving shock)
// Subjects=17
45.89	2.87	-13.76
62.22	-3.73	23.41
42.98	12.53	28.96
17.18	-15.57	-1.84
17.08	16.41	-1.18
4.78	8.53	63.19
1.45	-12.58	38.23
-37.36	-6.38	-1.99
-24.54	49.68	19.93
-43.54	22.3	39.17
-46.75	2.48	30.83
-56.28	-19.78	32.81

// Helmchen C, 2006: External vs. Internal, Activations
// Subjects=16
-30	-32	60
-34	-30	58

// Helmchen C, 2006: External = Internal, Activations
// Subjects=16
-60	-22	28
-62	-20	24
-40	-18	18
46	-14	18
54	-18	18
-32	6	6
-30	10	6
-32	14	4
-34	8	0
-32	32	-2
-36	8	-4
34	16	4
36	38	-4
40	30	0
-36	-14	10
38	-14	14

// Mohr C, 2008: Common Activity During Thermal Stimulation
// Subjects=15
26	-40	76
-46	-40	62
-66	-22	22
40	-12	66
-34	-4	66
-42	-2	60
-50	-2	52
-4	10	34
-58	14	32
-26	-52	72
38	-4	12
58	-14	8
22	16	-22

// Mohr C, 2008: Capsaicin-Treated 43 C vs. Untreated 43 C
// Subjects=15
-50	-24	20
56	6	6
-18	10	-4

// Mohr C, 2008: Capsaicin-Treated 0 C > Untreated 0 C
// Subjects=15
28	10	52
12	-26	-22

// Lopez-Sola M, 2010: Pain > Baseline, Control Activations
// Subjects=20
-36	0	-8
40	34	2
-36	32	12
46	34	36
-30	-8	-6
30	6	6
6	20	36
4	-50	-18

// Scheef L, 2012: preWalk: Pain > Heat (Activations)
// Subjects=20
20.71	-11.05	9.6
53.5	8.34	42.98
-64.52	-18.07	19.59
-64.44	-26.27	23.76
60.9	-21.26	24.49
67.28	-15.48	17.09
60.38	14.22	-9.26
37.88	6.78	4.18
62.67	6.45	-.69
-56.2	5.82	-.84
-42.21	9.81	-4.84
42.33	-15.23	9.65
35.76	-15.88	3.1
10.13	17.99	33.8
11.87	-20.19	-7.27
-9.78	-16.22	-9.54
-27.06	-65.49	-18.94
-23.01	-72.98	-41.8
-7.81	-74.53	-36.3
-11.95	-48.01	-16.44
-1.14	-52.33	-17.32
1.02	-65.39	-19.42
26.95	-65.3	-19.87
31.21	-60.28	-23.81
37.61	-54.29	-28.99
10.13	17.99	33.8
12.61	12.73	57.81
8.17	21.67	50.28

// Scheef L, 2012: postWalk: Pain > Heat (Activations)
// Subjects=20
67.28	-15.48	17.09
56.52	-19.57	19.92
40.03	8.91	3.94
62.68	4.32	-.48
55.06	8.24	-4.1
-40.06	11.95	-5.09
-56.13	4.11	3.81
-60.59	5.29	-6.32
9.83	-15.97	3.55
11.8	-16.35	-12.13
-11.68	-17.55	10.8
33.63	-20.04	4.67
18.57	-10.85	11.86
7.91	18.63	29.29
5.89	12.01	38.95
-5.07	18.48	28.41
5.24	-27.84	-19.85
-29.26	-63.58	-21.33
1.19	-76.16	-8.28
-9.67	-71.19	-11.94
-18.72	-68.81	-43.4
39.8	-85.85	-33.75
9.38	-43.42	-37.43
-9.78	-16.22	-9.54
6.18	6.54	60.78

// Scheef L, 2012: preRun: Pain > Heat
// Subjects=20
32.12	-13.03	56.67
27.94	-32.74	64.29
-64.48	-19.99	22.02
-55.96	-13.24	13.37
63.07	-23.38	24.67
53.24	-17.66	17.55
44.52	-15.02	11.83
40.03	8.91	3.94
60.4	14.33	-8.15
60.54	6.65	1.57
25.05	-17.42	10.16
18.57	-10.85	11.86
-20.51	-6.92	-1.31
-11.83	-8.81	0.97
11.87	-20.19	-7.27
8.11	12.43	43.35
7.97	19.05	33.73
35.77	48.74	16.88
-33.42	52.54	15.44
58.79	11.88	34.7
16.81	-16.67	41.6
-27.07	-63.37	-19.15
-31.52	-56.66	-27.58
-29.54	-58	-42.05
-44.29	8.2	0.96
-51.82	1.89	2.83
-9.78	-16.22	-9.54
-3.61	-43.67	-39.42
33.59	-15.99	2.03
-35.64	-20.15	-4.23

// Scheef L, 2012: postRun: Pain > Heat
// Subjects=20
60.9	-21.26	24.49
63.31	-33.63	41.37
-.64	16.03	36.42
5.95	12.42	43.39
7.94	18.84	31.51
37.88	6.78	4.18
37.78	21.35	-.62
18.57	-10.85	11.86
25.02	-15.5	7.73
-53.98	1.89	2.87
-46.49	7.88	-2.33
-66.68	-18.08	19.63
14.12	-14.03	1.04
-29.26	-63.58	-21.33
-7.54	-77.98	-15.79
-9.73	-58.53	-14.32
-27.39	-66.82	-44.57
56.23	2.38	2.06
56.12	10.26	-5.44

// Shukla S, 2011: Heat Pain > Baseline (Activation)
// Subjects=10
51.76	-45.4	35.95
48.19	3.54	8.46
41.96	18.5	37.39
28.92	55.72	24.38
-22.31	-16.43	4.26
6.66	21.2	34.22

// Shukla S, 2011: Minimal Intensity Acupuncture (MI-EA) > Baseline 
// (Activation)
// Subjects=10
51.27	12.13	-4.56
49.29	17	17.36
19.23	4.45	-4.66
-32.04	25.26	7.56

// Shukla S, 2011: MI-EA, Heat Pain > Baseline (Activation)
// Subjects=10
-34.24	64.09	14.37
9.73	8.85	11.81
31.03	55.47	21.03
44.69	33.44	-17.42
54.8	-63.56	7.32
-59.38	-59.27	31.7
6.45	-27.06	-11.91

// Shukla S, 2011: OI-EA, Heat Pain > Baseline (Activation)
// Subjects=10
51.24	11.79	-8.99
61.29	-42.94	25.59
61.09	-45	-1

// Iannilli E, 2008: Chemical Stimulation > Baseline
// Subjects=18
-44.39	49.03	1.4
49.72	48.06	8.86
43.19	41.14	4.05
-31.62	31.25	-17.23
58.22	17.51	-8.43
-12.2	54.07	-15.33
-27.81	11.4	22.77
43.29	-6.28	2.02
43.2	5.11	-2.47
-41.08	-18.25	-6.56
44.33	17.54	4.13
36.96	-5.16	14.34
-44.26	-14.55	-1.27
-31.25	0.05	4.91
-27.92	-2.51	11.83
17.43	-12.44	6.43
42.95	11.96	-21.07
36.49	5.55	-20.32
-11.63	24.42	23.45
14.24	36.11	20.73
23.64	45.77	-2.79

// Iannilli E, 2008: Electrical Stimulation > Baseline
// Subjects=18
49.43	51.41	-12.76
-44.59	56.29	-12.76
46.36	29.69	-3.83
49.31	46.12	-23.44
52.96	41.49	7.22
-1.77	38.57	36.45
-43.65	15.21	52.92
47.17	10.52	55.2
43.76	11.49	42.84
58.86	8.05	39.56
58.86	8.05	39.56
58.96	-39.38	37.53
-41.58	-26.01	36.8
-39.27	-20.5	49.66
25.83	-30.2	68.56
59.78	-25.94	20.49
-42.52	-42.4	45.16
55.91	-56.53	49.36
-33.9	-42.58	42.79
-14.63	-30.69	31.2
-11.85	11.82	3.41
10.94	7.2	10.2
51.67	16.97	-13.87
-41.29	11.87	-17.38
-11.65	-24.99	11.53

// Iannilli E, 2008: Mechanical Stimulation > Baseline
// Subjects=18
36.32	31.62	-28.5
-38.05	11.88	-17.44
-53.29	36.18	-20.71
36.79	58.11	13.69
-31.4	59.17	5.78
7.75	55.75	24.5
1.23	48.83	19.7
39.58	62.45	-20.4
46.36	55.94	1.42
55.04	49.69	3.01
-44.43	48.72	-1.93
-44.47	58.29	-2.87
7.78	-2.07	14.54
17.38	5.85	6.87
-11.62	0.4	19.1
-15.24	20.54	-6.36
-8.5	-5.94	8.47
-44.41	17.15	-6.65
46.27	15.88	-13.67
43.17	-11.57	-8.66
36.96	1.43	15.93
36.74	24.96	3.52
44.21	1.3	-8.83
46.36	-5.39	-11.57
-18.25	0.4	8.01
-11.56	17.29	27.52
18.68	20.59	26.68
-13.84	34.95	21.33
7.7	32.38	15.61
-48.05	1.05	-40.85
52.41	4.59	-42.91
-57.66	-4.74	-33.39

// Iannilli E, 2008: Positive Effect of Chemical Stimulus on the Electrical
// Subjects=18
43.29	-7.34	2.13
46.2	8.78	-20.81
52.83	52.56	-.6
-44.29	50.92	10.18
-8.32	18.37	27.36

// Iannilli E, 2008: Positive Effect of Chemical Sitmulus on the Mechanical
// Subjects=18
-34.48	-.92	6.18
43.33	38.89	14.36

// Iannilli E, 2008: Positive Effect of the Electrical Stimulus on the 
// Mechanical
// Subjects=18
49.82	32.42	13.77

// Iannilli E, 2008: Positive Effect of the Mechanical Stimulus on the 
// Electrical
// Subjects=18
23.68	51.5	1.12
2	61.85	-1.78
-27.97	55.11	19.57
11.51	58.1	-19.5
3.85	58.41	-27.24
-34.78	-9.8	-19.83
4.49	25.99	16.3
24.81	19.08	-1.29
48.33	9.64	-23.17

// Iannilli E, 2008: Conjunction Analysis: Chemical and Electrical
// Subjects=18
-37.95	23.55	-7.39
48.42	51.92	-7.19

// Iannilli E, 2008: Conjunction Analysis: Chemical and Mechanical
// Subjects=18
-44.43	48.72	-1.93
42.97	5.57	-20.44
50.7	54.99	2.56

// Iannilli E, 2008: Conjunction Analysis: Electrical and Mechanical
// Subjects=18
50.51	51.41	-12.77
-38.01	12.19	-14.11
46.27	15.88	-13.67

// Kattoor J, 2013: Pain > Baseline
// Subjects=21
-34	0	12
-32	8	2
42	10	-6
32	8	8
-62	-34	32
-62	-24	26
62	-28	40
-50	-32	26
60	-38	48
62	-24	30
-48	0	10
-24	34	12
-38	44	32
44	50	14

// Kattoor J, 2013: CS+ > CS- (Early Acquisition, Anticipatory)
// Subjects=21
4	-52	70
2	30	-2
-2	28	-2
4	-54	18
4	-90	16
-32	12	-28
50	-14	6
42	-6	-20
44	-28	-14
28	6	-12
-28	-24	6
26	8	-10
22	-70	-12
-40	-46	-24
-28	-62	-16
20	-70	-12
16	-68	-12
32	-66	-18
-18	-50	-16
-20	-76	-20
-38	-50	-26
6	-72	-10
-22	-50	-26

// Kattoor J, 2013: CS+ > CS- (Late Acquisition, Anticipatory)
// Subjects=21
24	2	-22

// Kattoor J, 2013: CS+> CS- (Extinction)
// Subjects=21
12	24	26
26	-66	26
-18	-80	50
-26	-70	40
-48	-46	6
-28	-36	0
-22	12	10
-40	-24	22
32	6	46
-20	36	-16

// Kattoor J, 2013: CS- > CS+ (Extinction)
// Subjects=21
-6	-58	34
26	12	46
-6	58	40
-10	48	22
4	54	46
4	42	24

// Kong J, 2013: Pain: LC > HC
// Subjects=48
-4	36	54
-2	58	20
-20	60	8
-44	38	-10
-34	22	-2
14	64	10
26	60	6
38	16	34
-38	-72	32
-36	-68	50
-52	-66	30
34	-68	30
30	-64	56
8	-80	-34

// Longo M R, 2012: Laser Stimulation > Baseline
// Subjects=14
-46	-12	36
-58	-6	26
58	-6	24
52	-10	42
44	-12	36
-2	-2	58
-4	12	42
-64	-6	14
48	12	-6
-48	10	-6
-2	20	32
2	20	30
10	2	72
-2	-92	22
-6	-82	-10
54	-36	56
-48	-4	0
18	-30	62
-18	-30	62
12	-76	48
-14	-4	16
-46	-10	8
24	-98	6
-16	18	2
34	-12	16
46	-8	6
42	-14	14
32	-18	6
32	-24	12
40	-12	-6

// Longo M R, 2012: Object > Hand
// Subjects=14
-16	-74	-8
50	0	-40
8	-86	20
-30	-28	56
46	-66	-42
32	-20	48
-42	-20	24
-68	-18	-6

// Longo M R, 2012: Hand > Object
// Subjects=14
-18	-62	66
-26	-84	38
24	-100	6
16	-68	64
-48	-72	-4
28	-80	42
-34	-94	10
16	-102	8
-16	-78	50
-24	-102	6
44	-74	-8
48	-64	-2
8	60	-18
38	-86	28
16	12	-10
-12	22	6
-4	16	4
24	16	-6

// Lu H, 2009: Control > Baseline
// Subjects=14
-42.47	17.72	-23.55
-4.64	4.16	58.95
-66.53	-27.89	29.56
-62.28	-24.03	24.63
-52.97	-11.81	-5.88
-53.94	-7.69	3.82
-46.78	4.63	-25.54
-37.82	19.06	2.02
-.6	29.42	41.82
-11.83	-9.87	1.07
-18.32	-6.7	0.87
-31.48	-1.61	-12.85
67.03	15.49	3.95
62.93	9.49	20.3
46.57	42.19	15.1
71.92	-38.27	37.2
65.13	-11.03	18.93
76.02	-30.03	21.74
62.7	-4.29	-.75
54.86	18.79	-17.47
39.89	16.59	-5.79
44.22	-7.42	-10.21
14.56	12.25	41.02
16.26	-9.77	0.59
33.43	5.83	-5.73
18.31	10.13	-4.78
13.86	-36.73	-23.6

// Lu H, 2009: Placebo > Baseline
// Subjects=14
-54.18	29.88	-7.74
-56.32	8.18	-10.04
-13.99	-8.82	1.01
-22.64	-6.72	0.95
52.98	35.11	7.85
8.2	26.23	53.19
42.17	6.58	1.89
16.26	-8.71	0.48
31.35	4.21	0.07
13.93	-57.05	-22.71

// Lu H, 2009: Control > Placebo
// Subjects=14
-35.26	0.19	29.61
-41.86	41.96	28.95
-60.01	7.42	39.4
-22.89	5.65	-15.96
-35.9	20.6	-16.1
-60.1	-21.69	26.6
-11	-57.31	56.18
-68.84	-11.5	21.26
-70.94	-11.09	25.73
-52.94	-13.73	-3.45
-51.08	6.95	-23.45
-46.06	-77.54	13.96
-48.44	-6.94	11.49
-16.23	-30.17	-9.17
-29	-9.1	10.26
67.07	9.21	5.69
35.89	33.2	22.89
69.6	-20.82	28.78
53.72	-12.96	56.29
60.29	8.07	-17.62
53.27	-61.24	10.65
40.06	9.12	6.16
14.61	14.79	45.25
14.15	31.03	12.27
18.5	-21.26	3.93
29.01	5.08	-13.43
33.42	12.31	-5.25

// Ochsner K N, 2006: Pain > Warm
// Subjects=13
0	-12	68
44	32	24
54	4	52
48	8	36
38	42	2
6	8	36
-2	-28	34
28	16	0
42	0	10
38	-22	12
44	-32	26
-70	2	2
54	-38	12
54	-36	32
66	-46	40
-42	-68	40
-20	0	14
-8	-2	6
16	-6	14

// Ochsner K N, 2006: Anxiety Sensitivity Index (ASI) Regression for (Pain > 
// Warm)
// Subjects=13
-10	48	0
-14	40	0

// Ochsner K N, 2006: Fear of Pain Questionnaire (FPQ) Regression for (Pain > 
// Warm)
// Subjects=13
30	40	-8
38	42	-8
32	48	-10

// Perini I, 2013: All Painful > All Nonpainful
// Subjects=18
45.93	51.62	11.15
-38.51	41.08	6.31
38.48	15.65	0.87
-35.18	9.38	8.93
41.75	24.1	13.51
60.93	9.36	0.02
-51.24	9.03	5.8

// Perini I, 2013: All Nonpainful > All Painful
// Subjects=18
6.23	49.76	-9.43
-14	46	-1.07
-24.17	13.93	53.03
29.27	9.93	51.64
-30.48	-19.15	52.53
-56.37	1.28	29.93
38.95	-15.73	49.22
47.45	-13.91	44.51
-.46	-39.86	57.27
-55.2	-14.15	36.78
-1.53	-32.21	59.99
-55.56	-9.12	-8.24
57.64	-5.86	-17.62
-43.52	-33.51	19.32
-20.82	-77.9	35.05
48.52	-69.97	21.32
27.27	-73.21	36.33
-29.79	-45	-6.64

// Perini I, 2013: All Press > All No-press
// Subjects=18
-.69	9.33	46.46
-2.83	6.05	45.64
-37.93	-15.59	57.9
-37.85	-31.2	62.55
51.29	12.3	-2.34
-41.57	-3.6	6.75
-47.86	-22.16	15.07
0.06	-59.85	-22.47
19.24	-53.65	-26.55
-12.68	-68.93	-14.87
-12.67	-16.12	7.47
12.93	-9.88	3.3
-19.3	21.14	-5.62
19.46	-1.95	22.64

// Perini I, 2013: All Heat > All Cold
// Subjects=18
9.61	48.23	11.85
3.6	29.33	57
6.67	47.69	46.5
44.76	43.98	-4.92
58.79	12.6	0.89
3.65	-12.94	47.16
-12.31	-22.3	51.47
6.74	-7.6	33.29
-3.26	18.06	-5.54
48.22	3.79	11.79
35.88	-37.35	58.87
-37.89	-34.88	56.17
16.72	-43.3	66.28
-37.85	-51	54.17
-5.72	-63.24	58.18
-28.62	-25.22	15.1
32.28	-21.68	14.11
48.22	3.79	11.79
-25.35	-60.86	8.02
29.13	-57.37	7.1
-15.65	-83.01	9.77
19.5	-14.73	22.59
3.31	-72.52	-21.44

// Perini I, 2013: All Painful Press > All Painful No-press
// Subjects=18
3.41	17.5	27.88
-35.74	-18.24	64.78
-31.4	-27.47	68.85
-54.04	-29.66	42.53
35.32	16.15	7.55
0.17	-68.6	-11.7
16.06	-66.61	-28.78
-3.04	-71.96	-13.61
-9.5	0.02	9.42
6.59	-15.75	10.56
-25.56	-13.54	0.71
25.66	5.8	-1.5
-3.34	18.35	-15.6

// Perini I, 2013: All Nonpainful Press > All Nonpainful No-press
// Subjects=18
0.3	11.9	38.42
-50.8	-25.96	48.88
-37.87	-24.85	62.02
-44.81	-.71	3.2
4.32	-49	-20.08
16.04	-53.67	-26.52
0.14	-19.47	4.25
-15.8	-8.77	20.27
9.68	22.6	10.65
-28.82	-4.3	-3.38

// Perini I, 2013: Conjunction: Painful Press and Nonpainful press
// Subjects=18
0.27	14.82	34.83
-38.06	27.05	58.78
-37.85	-31.2	62.55
-48.08	8.53	-.89
0.06	-59.85	-22.47
19.24	-53.65	-26.55
-9.45	-19.27	7.69
-15.79	-18.54	17.74
-3.18	-23.95	-12.06

// Russo A, 2012: 41C > Baseline, Healthy Controls
// Subjects=16
54.63	-9.37	6.13
-54.36	-13.2	7.7
38.44	31.77	2.86
-32.1	27.92	0.65
3.55	9.01	41.97
57.9	-21.78	10.48
35.28	19.06	3.97
-38.51	1.47	-10.44

// Russo A, 2012: 51C > Baseline, Healthy Controls
// Subjects=16
48.37	2.08	30.89
-34.88	-10.51	40.71
28.78	57.6	7.5
-25.68	47.76	8.95
35.31	19.32	7.29
-35.3	27.9	0.69
6.67	11.43	31.7
57.9	-21.78	10.48
61.37	-35.57	38.36
-57.31	-40.22	30.07
38.65	-15.56	10.18
12.97	-22.57	4.37
51.51	-41.37	5.5
-31.73	-77.02	6.1
-25.75	-68.23	-46

// Russo A, 2012: 53C > Baseline, Healthy Controls
// Subjects=16
58.08	-.18	42.12
-47.65	-10.08	47.51
32.14	42.79	22.08
-28.72	42.94	29.46
41.65	31.79	2.82
-35.3	27.9	0.69
3.55	9.01	41.97
57.9	-21.78	10.48
57.8	40.83	21.95
-63.83	-24.92	22.17
38.66	-18.73	10.44
12.97	-22.57	4.37
48.32	-37.96	8.6
-25.04	-60.87	49.28

// Song G H, 2006: Rectal Stimulation > Baseline, Healthy Controls 
// (Activation)
// Subjects=12
-1.73	20.66	55.56
-8.26	19.34	39.01
55.66	15.55	11.83
-30.9	50.16	26.65
-38.59	51.23	-.11
36.25	28.96	-5.8
-8.43	-12.04	4.84
-24.51	-1.64	3.04
-49.81	-21.35	39.56
-59.55	-17.15	25.93
65.66	-30.97	42.38
-29.85	-67.6	-23.7

// Song G H, 2006: Heterotopic Stimulation > Baseline, Healthy Controls 
// (Activation)
// Subjects=12
-5.03	25.16	45.18
55.68	17.93	14.98
-34.09	50.31	28.91
-40.64	54.27	11.92
39.51	19.72	-1.71
-5.23	-15.36	2.86
-18.07	0.85	7.22
-49.62	-43.5	55.91
2.21	-42.15	-13.94

// Song G H, 2006: Sham Stimulation > Baseline, Healthy Controls (Activation)
// Subjects=12
10.97	23.86	40.64
58.88	19	14.85
49.25	42.98	22.99
36.3	47.08	8.3
36.36	20.21	4.97
26.82	0.06	6.77
62.51	-35.85	48.4

// Stankewitz A, 2009: Ammonia > Air Puffs
// Subjects=23
36	18	-9
6	12	42
24	-57	6
42	-12	39
57	-21	27
9	-12	0
9	6	-3
12	-63	-21
51	-48	6
3	-36	-45
24	-3	-12
-39	0	-3
0	-3	42
-15	-66	9
-60	-18	30
-57	3	31
-9	-15	0
-9	-63	-21
-12	0	-3
-51	-60	6
-6	-39	-51
-18	0	-15
-6	36	6

// Strigo I A, 2013: High Pain Anticipation > Low Pain Anticipation, Healthy 
// Controls
// Subjects=22
35.21	31.49	-.42
-36.29	24.35	9.92
52.51	19.39	20.47
45.12	17.03	31.9
58.16	-44.39	34.67
0.36	-36.96	25.79
58.96	-38.41	1.82
52.4	-19.04	-8.65
12.89	11.7	7.07
-2.11	-30.54	-14.86
-39.65	-50.89	-40.61

// Strigo I A, 2013: Low Pain Anticipation > High Pain Anticipation, Healthy 
// Controls
// Subjects=22
28.87	-31.5	-16.26
-50.98	-10.24	31.95

// Kobayashi Y, 2009: VAS-i 3 > Baseline, Healthy Controls
// Subjects=8
48.49	12.08	50.12

// Kobayashi Y, 2009: VAS-i 5 > Baseline, Healthy Controls
// Subjects=8
2.49	-40.29	23.82
2.55	9.77	51.96
33.21	47.11	22.83
39.58	11.6	3.43

// Misra G, 2015: Pain Only > Baseline
// Subjects=15
0	26	31
-1	0	61
0	12	57
-47	-13	13
-26	-5	8
-22	8	-6
-16	17	6
-60	-33	24
-39	-40	47
-28	-52	51
-21	-74	-50
-30	-91	-1
-45	-70	3
39	16	3
24	10	-5
11	8	8
13	17	0
62	-28	20
50	-35	46
33	-60	-23
31	-87	-2
43	-76	-10
28	-68	35
40	5	-13
55	5	31

// Misra G, 2015: Conjunction Analysis: Force Only and Pain Only
// Subjects=15
0	9	48
1	0	62
2	7	57
-44	1	8
-24	9	1
-26	-5	5
-44	-71	4
-28	-92	-2
-15	-76	-45
38	18	4
39	2	12
47	-63	5
34	-87	-2
57	7	29
62	-21	37
63	-32	22
43	-41	49

// Misra G, 2015: Force Pain > Force Only
// Subjects=15
-1	13	39
-7	11	56
-1	33	27
-55	-20	14
-19	-71	43
-27	-58	-24
-5	-59	-7

// Misra G, 2015: Force Pain > Pain Only
// Subjects=15
-3	-5	57
-44	-20	52
-13	-19	7
-15	-69	-48
39	-8	55
62	-17	36
37	-43	54
37	-85	4

// Misra G, 2015: Force Pain > Force Warm
// Subjects=15
0	15	39
15	-80	-12

// Sevel L S, 2015: Pain > Rest
// Subjects=24
-6	8	41
6	5	56
0	-4	62
-6	23	26
15	-13	5
-21	14	-1
48	-34	23
21	17	2
60	-16	23
6	29	23
9	-25	-16
54	-46	29
54	-27	24
15	-49	71
-9	-19	2
33	44	29
33	-22	17
54	11	-7
54	-37	44
6	-25	23
-57	-22	14
-48	-37	50
33	2	5
18	11	11
-9	-79	5
0	-58	-7
12	-13	-13
33	23	2

// Matsuo Y, 2017: Pain > Rest, Healthy Controls
// Subjects=13
35.36	13.23	11.14
0.29	28.28	43.74
0.38	6.07	45.6
38.69	27.74	33.31
-2.83	-69.73	15.2

// Perlaki G, 2015: VAS 7 > VAS 1 (Activation)
// Subjects=18
-32	-20	18
36	8	6
-4	0	44
4	-12	-2
54	-2	6
38	-16	8
-36	4	10
-56	-2	8

// Petschow C, 2016: LPS > Baseline, Healthy Controls
// Subjects=13
-63	-31	19
-48	-31	19
-51	-19	22
45	-28	22
54	-37	19
63	-19	25
-21	-10	61
-12	-16	70

// Petschow C, 2016: HPS > Baseline, Healthy Controls
// Subjects=13
-33	-19	19
-57	-22	31
-54	-28	19
57	-19	16
45	-31	22
57	-43	19
15	-7	67
0	-13	67
-15	-7	67
51	2	7
51	17	1
36	11	7
-39	2	-14
-39	-1	-5
-33	8	7
0	5	40
-6	2	46

// Asghar M S, 2016: Placebo: Pain > Baseline (Activation)
// Subjects=27
-34	10	42
-12	8	50
66	-18	24
-56	-22	26
46	-32	38
50	-44	52
-50	2	6
40	-18	22
60	-30	-4
-36	-74	-18
38	-10	22
-44	-10	4
6	-18	-20
-2	-58	-18
40	-68	-30
44	-78	-34
26	-80	-24
30	-78	-20
36	-80	-42

// Asghar M S, 2016: CGRP: Pain > Baseline (Activation)
// Subjects=27
-40	12	12
-30	32	4
40	22	-2
32	22	-2
-32	0	16
14	-20	-24
-14	-22	-24

// Asghar M S, 2016: Sumatriptan + CGRP: Pain > Baseline (Activation)
// Subjects=27
-4	6	44

// Bagdanov V B, 2015: Early Cold > Baseline
// Subjects=24
-3	-73	49
-57	-70	-75
45	5	58
27	-4	-8
6	-40	46
3	-43	16
12	47	-11
-9	29	-17
48	23	28

// Bagdanov V B, 2015: Sustained Cold > Baseline (Activation)
// Subjects=24
-21	-25	25
18	-16	28
-18	-1	25
-18	-13	28
12	-37	13
-33	-22	19
-21	-25	25
-12	-19	19

// Bagdanov V B, 2015: Laser > Baseline
// Subjects=24
36	17	-2
-30	20	-5
45	-16	16
-39	-7	-2
-30	14	7
42	-7	10
48	11	19
18	-4	-14
-21	-4	-14
-15	8	-11
9	2	4
3	-22	31
-60	-28	22
63	-22	22
0	20	25
-60	-49	43
33	-49	43
60	-40	37
48	38	7
-15	-34	-8
-18	-7	-14
6	-28	4
12	-10	10
54	-10	16
27	29	-17
12	-64	31
-48	38	19
36	53	31
6	11	61
0	-31	-5
-60	-60	7
-18	-73	-32
12	-91	-26
-9	8	4
9	5	7

// Sinke C, 2017: Pain > Control
// Subjects=42
-36	8	6
-4	14	50
0	24	30
38	-18	18
54	-2	8
34	8	14
54	-22	24
14	-10	8
8	-16	28
6	14	36
2	8	40
2	24	28
20	-44	68

// Sinke C, 2017: Control > Pain
// Subjects=42
-20	-10	-24
28	-28	-24
32	-14	-22

// Sinke C, 2017: Postive Expectancy > Negative Expectancy
// Subjects=21
-24	-74	-8

// Sinke C, 2017: Stimulation X Expectancy (Positive Expectancy 
// [Pain>Control]) > (Negative Expectancy [Pain>Control])
// Subjects=21
-2	38	8
-4	22	-8
-6	46	2
-30	-36	-2
58	-54	40
8	44	22
32	-38	2

// Bräscher A K, 2016: Uncontrollable Pain > Uncontrollable Warm
// Subjects=23
-28	-66	-28
-28	-66	-28
24	-58	-28
38	8	8
14	-20	10
-18	-20	14
6	20	30
36	14	6
-32	16	4
56	-20	22
-36	-10	64
-36	-10	64
22	-2	54
-42	-36	54
-36	-26	56
16	-64	42
16	-64	42
10	-62	60
-16	-62	58

// Bräscher A K, 2016: Controllable Pain > Controllable Warm
// Subjects=23
42	-12	14
42	-12	14
38	-14	16
-38	12	-4
56	0	4
4	12	44
12	-6	6
-14	-18	16
6	18	60
-26	-62	-22

// Bräscher A K, 2016: Positive Correlation between Pain Rating and Activation 
// during Uncontrollable Pain
// Subjects=23
10	28	50
10	28	50
10	22	32
2	38	16
46	20	-10
46	20	-10
50	20	-4
44	20	0
54	8	0
44	10	-2
8	-84	-10
8	-84	-10
-44	16	-2
-44	16	-2
-32	20	-14
-38	10	0
4	-2	6
4	-2	6
14	0	2

// Bräscher A K, 2016: (Uncontrollable Pain > Uncontrollable Warm) > 
// (Controllable Pain > Controllable Warm)
// Subjects=23
-34	-26	54
-34	-26	54
-38	-30	52

// Jensen K B, 2015: High Pain > Low Pain
// Subjects=24
36	5	7
-33	-16	16
0	17	34
0	-16	7

// Jensen K B, 2015: Placebo Main Effect: Low Pain > Control Pain
// Subjects=24
9	26	-8

// Jensen K B, 2015: Placebo: Nonconscious > Conscious
// Subjects=24
36	29	-2

// Jensen K B, 2015: Placebo: Conscious > Nonconscious
// Subjects=24
-3	-91	28

// Jensen K B, 2015: Nocebo Main Effect: High Pain > Control Pain
// Subjects=24
0	-13	31
-42	-4	4
42	2	-14
39	-1	-2
-6	-19	-5

// Jensen K B, 2015: Nocebo: Nonconscious > Conscious
// Subjects=24
9	-16	-5
6	-1	10
30	-4	-14
33	-10	-14

// Shinozaki T, 2016: Healthy Controls: Noxious Heat Palm > Baseline
// Subjects=15
-34	-22	4
42	-44	18
-32	16	4
-26	-10	64
8	-16	58
12	20	54
-20	-58	-24
4	20	28
12	-64	-28
-52	-24	28
46	2	40
12	-76	12

// Shinozaki T, 2016: Healthy Controls: Noxious Heat Lip > Baseline
// Subjects=15
-28	2	2
50	44	16
-26	-60	-28
48	-52	42
18	-80	-28

// Shinozaki T, 2016: Healthy Controls: Noxious Heat Lip and Warm Heat Lip > 
// Baseline
// Subjects=15
-6	-40	32

// Bouhassira D, 2013: Non-painful > Rest (Healthy Controls)
// Subjects=11
-54	-18	18
48	-4	32
16	-10	-4
-36	18	0
-4	36	24
0	-20	34
32	42	32
-32	32	34
-36	-74	-38

// Bouhassira D, 2013: Painful > Rest (Healthy Controls)
// Subjects=11
-36	-29	48
-24	-32	68
64	-34	24
-46	-40	40
-38	-24	62
-12	14	60
-14	-14	10
-38	8	16
-36	-14	2
-14	32	26
-28	52	28
52	12	10
-22	24	54
-20	-78	-20
28	-10	8
14	26	-2
28	-28	-20

// Hall G B C, 2010: Supra-threshold > Sub-threshold (Healthy Controls)
// Subjects=6
11.83	-.28	3.63
-6.34	1.72	3.67
-60.68	-46.36	6.09
-60.92	6.08	-3.88
35.32	-12.37	-3.44
-41.56	-12.23	5.24
-38.06	7.24	50.41
-3.28	38.75	0.53
-3.93	26.57	49.51
-3.39	26.64	-18.53
37.41	58.51	18.48
-25.57	57.68	27.08

// Baliki M N, 2006: Random Effects: Thermal > Rest (Healthy Controls)
// Subjects=11
-2	-18	8
4	-20	10
16	12	8
24	8	-2
-24	14	-2
-12	16	8
46	-2	-14
46	-8	-2
-10	-94	-18
-32	-88	-20
0	18	34
2	12	46
18	28	58
-30	18	6
-48	22	-16
-46	4	-2

// Pujol J, 2009: Data-Driven: 4 kg/cm > Rest (Healthy Controls)
// Subjects=9
-51	-27	48
-54	-28	26
56	-17	17
-59	-23	15
-36	15	2
36	15	-1

// Pujol J, 2009: Model-Driven: 4 kg/cm > Rest (Healthy Controls)
// Subjects=9
-51	-44	49
36	20	-4

// Pujol J, 2009: Matched-Subjective: 6.8 kg/cm > Rest (Healthy Controls)
// Subjects=9
-54	-15	48
-33	-29	62
54	-21	48
-60	-22	26
56	-16	23
-48	-20	18
-33	-2	11
39	-3	-2
-6	-1	36
0	0	55
54	13	35
-30	-62	-17

// Zhao Y, 2011: L Clenching > Rest (Healthy Controls)
// Subjects=14
-56.25	17.42	-3.11
-44.42	12.69	-8.45
-52.68	4.62	20.51
-50.84	7.66	-4.48

